Multi-heart plate – modular 3D cardiac chambers platform for volumetric assays
The measurement system addresses the challenges of complex fabrication and invasive methods in cardiac chambers by using a distance sensor and tubular element to non-invasively determine cardiac functional parameters, ensuring accurate and scalable measurements.
Patent Information
- Application Number
- PCT/NL2026/050127
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-09
- Filing Date
- 2026-05-08
- Publication Date
- 2026-11-12
AI Technical Summary
Existing engineered cardiac chambers suffer from complex fabrication, lack of standardization, limited scalability, and reliance on invasive and labor-intensive methods for measuring cardiac functional parameters, leading to measurement uncertainty and high costs.
A measurement system comprising a distance sensor, module, and control system, with a holder and insert, where the insert includes a tubular element with specific diameters and alignment features, allowing non-invasive determination of cardiac functional parameters by measuring fluid levels in the tubular element.
Enables accurate and sensitive measurement of cardiac functional parameters without interference, reducing the risk of detachment and leaks, and facilitating scalable and reproducible results.
Smart Images

Figure NL2026050127_12112026_PF_FP_ABST
Abstract
Description
[0001] Multi-Heart Plate - Modular 3D cardiac chambers platform for volumetric assays
[0002] FIELD OF THE INVENTION
[0003] The invention relates to a measurement system. The invention further relates to a measurement method for measuring a cardiac functional parameter of a cardiac chamber model. Further, the invention relates to a cardiac model. Additionally, the invention relates to a method for preparing a cardiac model. The invention further relates to a system for preparing a cardiac model. Further, the invention relates to a use of the measurement system or the cardiac model.
[0004] BACKGROUND OF THE INVENTION
[0005] Measurement systems are known in the art. For instance, Li, R.A. et al. (2018), Biomaterials 163, p. 116-127 describes an in vitro biomimetic model of a pumping human heart chamber. A three-dimensional electro-mechanically coupled, fluid-ejecting miniature human ventricle-like cardiac organoid chamber (hvCOC) is engineered from human pluripotent stem cell (hPSC)-derived ventricular cardiomyocytes (hvCM) embedded in a collagen-based extracellular matrix hydrogel.
[0006] EP3563368B1 describes a system, method, and apparatus for a patient simulator that interacts with a diagnostic or therapeutic medical device. The system includes a computing device coupled to a patient module. The patient module includes hydraulic equipment that simulates a baseline fluid interconnection with a therapeutic device. The computing device manages physical and virtual data, provides algorithmic calculations for simulating hypothetical patient vital signs, long-term clinical course, and simulates related fluid properties. The simulation system automatically executes a step-wise clinical scenario, specified in a spreadsheet format of patient conditions and equipment scenarios, that also includes audio / visual stimuli of operating room and diagnostic clinic environments, along with data recording capabilities. The therapeutic device can be a heart lung machine (HLM), an extracorporeal membrane oxygenation (ECMO) machine, an emergency cardiac life support (ECLS) device, a ventricular assist device (VAD), a dialysis machines, a hyperthermic intraperitoneal chemotherapy (H1PEC) machine, and an aortic balloon pump.
[0007] US2021371790A1 describes systems and methods including a housing configured to receive and engage a hollow tissue structure within a fluid chamber of the housing. A first pair of flow channels and a second pair of flow channels of the housing are fluidly coupled to the fluid chamber. The housing fluidly couples the first pair of flow channelsand fluidly couples the second pair of flow channels via a second flow path such that a change in a fluid pressure differential between a first fluid in the first flow path and a second fluid in the second flow path deflects at least a portion of the hollow tissue structure causing a change in flow of the first fluid through the first pair of flow channels or a change in flow of the second fluid through the second pair of flow channels.
[0008] SUMMARY OF THE INVENTION
[0009] Injuries to the heart or the blood circulation, referred to as cardiovascular diseases, may globally be amongst the most common causes of death and disability. This high mortality rate may at least to some extent stem from issues in cardiac research. Especially, research may be in need of more accurate human-based models, instead of relying on animal models for drug testing and disease modelling. Although existing in vitro cardiac models like organoids, heart-on-chips, and engineered heart tissues may be available, such models may fall short in replicating the heart’s fluid-pumping function. Engineered cardiac chambers may be able to address this gap. However, existing engineered cardiac chambers may suffer from complex fabrication, lack of standardization, and limited scalability. In addition, these systems may rely on indirect and / or invasive detection methods to determine volumetric readouts, which may introduce measurement uncertainty and / or may affect the properties being measured. Further, invasive detection methods may be relatively labor-intensive and / or relatively difficult to scale up, leading to relatively high costs. Hence, it is an aspect of the invention to provide an alternative measurement system, which preferably further at least partly obviates one or more of above-described drawbacks. The present invention may have as object to overcome or ameliorate at least one of the disadvantages of the prior art, or to provide a useful alternative.
[0010] According to a first aspect, the invention provides a measurement system for measuring a cardiac functional parameter of a cardiac chamber model. The measurement system may comprise a distance sensor, a module, and a control system. Further, the module may comprise a holder and an insert. Especially, the holder may be configured to host the cardiac chamber model and at least part of the insert. Further, the holder may comprise an alignment means. The insert may comprise an alignment section and a tubular element. Especially, the alignment section may comprise an alignment element. The alignment element may be configured to interact with the alignment means. Further, the tubular element may be configured (i) intersecting with the alignment section, and (ii) (partially) extending from the alignment section at an alignment section first face. The tubular element may have a firstinternal (equivalent circular) diameter (Di) at a tubular element first end. In embodiments, 0.7 mm < Di < 2.3 mm, such as 1.0 mm < Di < 2.0 mm. The tubular element first end may be configured to extend into the holder (during use of the measurement system). Further, the tubular element first end may comprise one or more first end protrusions. Especially, the one or more first end protrusions may be configured to support the cardiac chamber model. The tubular element may further have a second internal (equivalent circular) diameter (D2) at a tubular element second end opposite the tubular element first end. In embodiments, 2.3 mm < D2 < 3.7 mm, such as 2.5 mm < D2 < 3.5 mm. Further, the tubular element may have a central axis (AT) perpendicular to the second internal diameter (D2) (and to the first internal diameter (Di)). The distance sensor may be configured to emit a sensor signal along a first axis (Ai) configured at a first angle (ai) with the central axis (AT). In embodiments, ai < 30°, such as oil < 20°. Further, the distance sensor may be configured to determine a distance to a fluid (level) in the tubular element. Additionally, the distance sensor may be configured to provide a distance signal to the control system. Especially, the control system may be configured to determine the cardiac functional parameter based on the distance signal (and the sensor signal).
[0011] Hence, in specific embodiments, the invention provides a measurement system for measuring a cardiac functional parameter of a cardiac chamber model, wherein the measurement system comprises a distance sensor, a module, and a control system, wherein the module comprises a holder and an insert, wherein the holder is configured to host the cardiac chamber model and at least part of the insert, wherein the holder comprises an alignment means; wherein the insert comprises an alignment section and a tubular element, wherein: (A) the alignment section comprises an alignment element, wherein the alignment element is configured to interact with the alignment means, wherein the tubular element is configured (i) intersecting with the alignment section, and (ii) extending from the alignment section at an alignment section first face; (B) the tubular element has a first internal diameter (Di) at a tubular element first end, wherein 1.0 mm < Di < 2.0 mm; wherein the tubular element first end is configured to extend into the holder; wherein the tubular element first end comprises one or more first end protrusions; wherein the one or more first end protrusions are configured to support the cardiac chamber model; (C) the tubular element has a second internal diameter (D2) at a tubular element second end opposite the tubular element first end, (wherein 2.5 mm < D2 < 3.5 mm;) wherein the tubular element has a central axis (AT) perpendicular to the second internal diameter (D2); and (D) the distance sensor is configured to emit a sensor signal along a first axis (Ai) configured at a first angle (ai) with the central axis (AT); wherein 0° < oti < 20°; wherein the distance sensor is configured to determine a distance to a fluid in the tubularelement; wherein the distance sensor is configured to provide a distance signal to the control system; and wherein the control system is configured to deteimine the cardiac functional parameter based on the distance signal.
[0012] In embodiments, the (inner) equivalent circular diameter of the tubular element may be monotonically non-decreasing from the tubular element first end to the tubular element second end, i.e., when moving from the tubular element first end to the tubular element second end the (inner) equivalent circular diameter may (locally) remain constant or may increase.
[0013] During use of the measurement system, (and in the presence of a cardiac chamber model,) the cardiac chamber model may especially be configured fluidically coupled with the tubular element. As such, contraction of the cardiac chamber model (hosting a fluid) may result in a change in fluid level in the tubular element, which change in fluid level may be measured using the distance sensor. The measurement system, wherein especially D2 > Di, may facilitate determining the cardiac functional parameter in a non-invasive manner with the distance sensor (i.e., without manipulating or interfering with the cardiac chamber model), thereby providing a more accurate (and / or realistic) measurement of the cardiac functional parameter. Especially, the relatively larger second internal diameter (D2) (compared to Di) may prevent interference between a wall of the tubular element and the sensor signal, thereby improving the accuracy and sensitivity of the measurement. Further, the one or more first end protrusions may provide the benefit that the cardiac chamber model may be supported by the first end protrusions, thereby reducing the chance that the cardiac chamber model may detach from the tubular element during measurements. Such first end protrusions may further improve the contact between the tubular element and the cardiac chamber model (e.g. by providing a larger surface area for attachment), thereby preventing (fluid) leaks at the interface between the cardiac chamber model and the tubular element which could lead to incorrect results.
[0014] The measurement system may comprise a module. Further, the module may comprise a holder and an insert. The holder may be configured to host the cardiac chamber model and (at least) part of the insert. Hence, the holder may be at least partially hollow (i.e., the holder may comprise a cavity). Further, the holder may comprise an alignment means. The alignment means may comprise one or more of an alignment protrusion, an alignment cavity (or through opening), and a specific shape of another element of the holder. In embodiments, the holder may comprise a holder central opening through which the insert may at least partially extend (see also below), wherein the alignment means may be a specific (non-symmetric) shape of the holder central opening (such that the insert may only fit into the holder central opening when properly aligned). Alternatively, and especially, the alignment means may comprise thealignment protrusion. The alignment protrusion may be configured protruding from the holder (especially from the holder lid, see below) in a direction parallel to the central axis (AT).
[0015] The holder may comprise a plurality of alignment means, such as > 1 alignment means, especially > 2 alignment means, like > 3 alignment means. Additionally or alternatively, the holder may comprise < 6 alignment means, such as < 5 alignment means, especially < 4 alignment means. Each of the plurality of alignment means may in embodiments be individually selected from the group comprising an alignment protrusion, an alignment cavity (or through opening), and a specific shape of another element of the holder. Yet, especially, each of the plurality of alignment means may be the same. For instance, the holder may comprise a plurality of alignment protrusions.
[0016] Hence, the holder may comprise one or more alignment protrusions, configured extending from the holder (especially from the holder lid) in a direction parallel to the central axis (AT). Each of the alignment protrusions may have a protrusion height (Hp) parallel to the central axis (AT). In embodiments, the protrusion height (Hp) may (for each of the alignment protrusions individually) be selected from the range of > 1.5 mm, such as from the range of > 2.0 mm, especially from the range of > 2.5 mm. Additionally or alternatively, the protrusion height (Hp) may (for each of the alignment protrusions individually) be selected from the range of < 4.0 mm, such as from the range of < 3.5 mm, especially from the range of < 3.0 mm. Further, each of the alignment protrusions may have a protrusion diameter (Dp) perpendicular to the central axis (AT). The protrusion diameter may especially be an equivalent circular diameter (see below). Hence, the alignment protrusions may have one of a circular, elliptical, and simple (regular) polygonal shape (wherein the sides of the polygon may be straight or curved) in a cross-section perpendicular to the central axis (AT), wherein said shape may have the equivalent circular diameter Dp. In embodiments, the protrusion diameter (Dp) may (for each of the alignment protrusions individually) be selected from the range of > 1.5 mm, such as from the range of > 2.0 mm, especially from the range of > 2.5 mm. Additionally or alternatively, the protrusion diameter (Dp) may (for each of the alignment protrusions individually) be selected from the range of < 4.5 mm, such as from the range of < 4.0 mm, especially from the range of < 3.5 mm.
[0017] The equivalent circular diameter (or ECD) of an (irregularly shaped) two-dimensional shape is the diameter of a circle of equivalent area. For instance, the equivalent circular diameter of a square with side a is 2a / SQRT(rt). For a circle, the diameter D is the same as the equivalent circular diameter D. Would a circle in an xy-plane with a diameter D bedistorted to any other shape (in the xy-plane), without changing the area size, then the equivalent circular diameter of that shape would be D.
[0018] The holder may further comprise a holder cup. The holder cup may be configured to (during use of the holder) host the cardiac chamber model. Especially, the holder cup may be a hollow holder cup (wherein the holder cup may be defined by a cup wall). The holder cup may have an internal cup height (He) parallel to the central axis (AT). The internal cup height (He) may be selected from the range of > 10 mm, such as from the range of > 14 mm, especially from the range of > 18 mm. Additionally or alternatively, the internal cup height (He) may be selected from the range of < 35 mm, such as from the range of < 30 mm, especially from the range of < 25 mm. Further, the holder cup may have an internal cup width (Wc) and internal cup length (Lc) (both) perpendicular to the central axis (AT), wherein the internal cup width (Wc) may further be perpendicular to the internal cup length (Lc). In embodiments, the internal cup width (Wc) and internal cup length (Lc) may each be individually selected from the range of > 15 mm, such as from the range of > 17.5 mm, especially from the range of > 20 mm. Additionally or alternatively, the internal cup width (Wc) and internal cup length (Lc) may each be individually selected from the range of < 30 mm, such as from the range of < 27.5 mm, especially from the range of < 25 mm. The internal cup height (He), internal cup width (Wc), and the internal cup length (Lc) may define a cup volume (Vc) of the holder cup. In embodiments, the cup volume (Vc) may be selected from the range of > 4 cm3, such as from the range of > 5 cm3, especially from the range of > 6 cm3. Additionally or alternatively, the cup volume (Vc) may be selected from the range of < 20 cm3, such as from the range of < 15 cm3, especially from the range of < 12 cm3.
[0019] The holder cup may have a cross-sectional shape in a cross-section of the holder cup perpendicular to the central axis (AT). In embodiments, the cross-sectional shape may be selected from the group comprising a circle, an ellipse, and a simple (regular) polygon (e.g. a square or rectangle), wherein the sides of the polygon may be straight or curved. Further, as indicated above, the holder cup may be defined by a cup wall. The cup wall may especially comprise (such as consist of) a transparent material. Further, the cup wall may comprise (such as consist of) a biocompatible material. In embodiments, the cup wall may comprise a transparent, biocompatible, polymeric material and / or a transparent, biocompatible, inorganic material. The cup wall may comprise a biocompatible photopolymer resin, e.g. suitable for 3D printing. Additionally or alternatively, the cup wall may comprise one or more of glass, silicone, polymethyl methacrylate (PMMA), polyolefin (PO), polylactic acid (PLA), poly(lactic-co-glycolic) acid (PLGA), polystyrene (PS), polypropylene (PP), polyvinylchloride (PVC), polyethylene (PE), polyurethane (PU), polycarbonate (PC), polyethylene terephthalate (PET), polydimethylsiloxane (PDMS), and polyetheretherketone (PEEK).
[0020] In embodiments, the holder cup may comprise an electrically insulating and / or biocompatible material, such as at least an electrically insulating material. For instance, the holder cup may comprise a polyimide. Further, the holder cup may comprise one or more electrodes. In embodiments, the holder cup may comprise > 2, such as > 3, like > 4, electrodes. Additionally or alternatively, the holder cup may comprise < 50, such as < 45, like < 40, electrodes. Especially, the holder cup may comprise two electrodes. The electrically insulating material may be configured to support the one or more (such as two) electrodes. Hence, the one or more (such as two) electrodes may be configured facing the inside of the holder cup. Especially, the one or more electrodes may be configured to provide electrical stimulation to the cardiac chamber model. Additionally or alternatively, the one or more electrodes may be configured to detect an electrical signal from the cardiac chamber model. In embodiments, the one or more electrodes may transmit the electrical signal, detected from the cardiac chamber model, to the control system. Further, the control system may be configured to determine at least one cardiac functional parameter based on the electrical signal. The holder cup, such as the electrically insulating material, may be configured as a flexible film. Alternatively, the holder cup, such as the electrically insulating material, may be configured as a rigid holder cup.
[0021] The holder cup may further comprise one or more electrical tracks. Especially, each of the one or more electrodes may be configured electrically coupled to at least one of the electrical tracks. The one or more electrical tracks may be configured to electrically couple the one or more electrodes to a power source. In embodiments, each of the one or more electrical tracks and the one or more electrodes may comprise an individually selected electrically conductive material. The electrically conductive material may be (individually) selected from the group comprising silver, copper, gold, aluminum, nickel, cobalt, iron, tungsten, platinum, tin, carbon-based materials (e.g. graphite), PEDOT:PSS (i.e., a composite of poly(3,4-ethylenedioxythiophene and polystyrene sulfonate), and alloys or composites thereof. The electrically conductive material may be biocompatible (with the cardiac chamber model). Especially, the one or more electrical tracks may comprise silver. Further, the one or more electrodes may comprise a carbon-based material. Carbon may be biocompatible. Further, silver may have a relatively low electrical resistance. Hence, in specific embodiments, the holder cup comprises one or more electrodes. Placing electrodes in the holder cup may facilitate providing a holder cup with integrated electrodes, thereby reducing or eliminating the need to introduce external electrodes into the module. As such, the risk of contamination and / orfalse measurement results may be reduced, and / or the module may be relatively more user-friendly. Further, integrated electrodes may facilitate providing more reproducible results, as the one or more electrodes may be placed at the same location each time and / or between samples. Additionally, placing the electrodes in the holder cup may facilitate placing the electrodes closer together compared to external electrodes, thereby providing the benefit that the strength of the electrical field may be reduced, thereby reducing the potential side effects of the electrical field on the cardiac chamber model.
[0022] The one or more electrodes (and the one or more electrical tracks) may be comprised by the cup wall. Yet, in embodiments, the holder cup may comprise, such as be defined by, the cup wall and a cup base. Especially, the cup base may (at least partially) be configured perpendicular to the central axis (AT). Further, the cup wall may be configured extending from the cup base (and defining the internal cup height (He)). In embodiments, one or more of the cup wall and the cup base may comprise the one or more electrodes (and one or more electrical tracks). For instance, the cup wall may comprise the one or more electrodes. Yet, especially, the cup base may comprise the one or more electrodes (wherein the cup wall may be free from electrodes). Hence, in embodiments, the cup base may be configured as a flexible film (wherein the cup wall may be a rigid wall). The cup base may further comprise the one or more electrical tracks (wherein the cup wall may be free from electrical tracks). Hence, in embodiments, the holder cup comprises a cup wall and a cup base, wherein the cup base is configured perpendicular to the central axis (AT), wherein the cup wall is configured extending from the cup base, and wherein the cup base comprises one or more electrodes. In embodiments, the cup base and the cup wall may be separate elements, wherein, during use of the holder cup, the cup wall and the cup base may be fixated to each other (e.g. using a clamp, an adhesive, or pressure). Especially, the cup base and the cup wall may be fixated to each other such, that a watertight seal is provided between the cup base and cup wall.
[0023] The holder may further comprise a holder lid. The holder cup may be configured to support the holder lid. In embodiments, the holder lid may be configured (at least) partially extending into the holder cup. Alternatively, the holder lid may be configured (supported) on top of the holder cup (such as especially on a top edge of the cup wall). The holder lid may comprise the (plurality of) alignment means. Further, the holder lid may comprise a holder central opening. The holder central opening may be configured fluidically coupled with the holder cup. That is, (during use of the holder,) the holder central opening may provide access to (an inside of) the holder cup. Further, (during use of the holder,) the insert may be configured at least partially extending (into the holder cup) through the holder central opening. The holdercentral opening may have a cross-sectional shape in a cross-section perpendicular to the central axis (AT), wherein the cross-sectional shape may be selected from the group comprising a circle, an ellipse, and a simple (regular) polygon, wherein the sides of the polygon may be straight or curved (e.g., the shape may be a rectangle or a stadium). Further, the holder central opening may have a central opening equivalent circular diameter Dco(perpendicular to the central axis (AT)). In embodiments, Dco> 2 mm may apply, such as Dco> 2.3 mm, especially Dco > 2.5 mm. Additionally or alternatively, Dco< 20 mm may apply, such as Dco< 15 mm, especially Dco< 10 mm. Would the holder lid comprise a plurality of alignment means, the plurality of alignments means (such as the plurality of alignment protrusions) may especially be distributed around the holder central opening. Hence, in specific embodiments, the holder may comprise a holder cup and a holder lid, wherein the holder cup may be configured to host the cardiac chamber model, wherein the holder lid may comprise the alignment means and a holder central opening, and wherein the insert may be configured at least partially extending through the holder central opening. Such a holder may provide a modular system, such that different holder lids (differing in e.g. the number or type of alignment means, or the size and / or shape of the holder central opening) may be used with the same holder cup. Further, such a holder may be relatively easier to clean and / or disinfect, as the holder may be disassembled for easy access.
[0024] The holder lid may further comprise a lid opening. The lid opening may provide access to (the inside of) the holder cup after placement of the insert onto the holder lid (and into the holder central opening). Hence, the lid opening may be (a through opening) configured fluidically coupled with the holder cup. Further, the lid opening may have a lid opening shape in a cross-section of the lid opening perpendicular to the central axis (AT). In embodiments, the lid opening shape may be selected from the group comprising a circle, an ellipse, and a simple (regular) polygon, wherein the sides of the polygon may be straight or curved (e.g., the shape may be a rectangle or a stadium). Further, the lid opening may have a lid opening equivalent circular diameter (Di0) (in a cross-section) perpendicular to the central axis (AT). In embodiments, Di0> 1.5 mm may apply, such as Di0> 2 mm, especially Di0> 3 mm. Additionally or alternatively, Di0< 10 mm, such as Di0< 9 mm, especially Di0< 8 mm.
[0025] The holder lid may comprise a plurality of lid openings. Especially, the holder lid may comprise > 1, such as > 2, especially > 3 lid openings. Additionally or alternatively, the holder lid may comprise < 5, such as < 4, especially < 3 lid openings. Hence, the holder lid may comprise the (plurality of) alignment means and the (plurality of) lid opening(s). Especially, the alignment means may comprise the (plurality of) alignment protrusion! s) (asdefined above). Further, the holder lid may comprise the holder central opening. The alignment protrusion(s) and the lid opening(s) may be configured distributed around the holder central opening. Further, in embodiments, (each of) the alignment protrusion(s) may be configured closer to the holder central opening than (each of) the lid opening(s). That is, the alignment protrusion(s) may be configured between the lid opening(s) and the holder central opening. Hence, in specific embodiments, the holder lid may comprise a lid opening, wherein the alignment means may comprise an alignment protrusion, and wherein the alignment protrusion may be configured between the lid opening and the holder central opening. Configuring the alignment protrusion between the lid opening and the holder central opening may provide the benefit that, would the holder central opening and the alignment protrusions be covered by the insert during use of the module, the lid opening may still allow access to the holder cup.
[0026] The module may comprise the insert. Further, the insert may comprise an alignment section and a tubular element. The insert may be a monolithic element. Alternatively, the alignment section and the tubular element may be configured mechanically coupled (e.g. by an adhesive or fixating means) and in physical contact. The insert may comprise an insert material. The insert material may comprise (such as be) a transparent material. Further, the insert material may comprise (such as be) a biocompatible material. In embodiments, the insert material may comprise a transparent, biocompatible, polymeric and / or inorganic material. The insert material may comprise a biocompatible photopolymer resin. Additionally or alternatively, the insert material may comprise one or more of glass, silicone, PMMA, PO, PLA, PLGA, PS, PP, PVC, PE, PU, PC, PET, PDMS, and PEEK. Would the alignment section and the tubular element be configured mechanically coupled (i.e., would the insert not be a monolithic element), the insert material may be individually selected for each of the alignment section and the tubular element.
[0027] The alignment section may be configured at least partially supported by (i.e., op top of) the holder lid. Further, the alignment section may be configured at least partially extending through the holder central opening. Hence, the alignment section may comprise an alignment section protrusion, wherein the alignment section protrusion may be configured at least partially extending through the holder central opening. In embodiments, the alignment section protrusion may have a cross-sectional shape perpendicular to the central axis (AT), wherein the cross-sectional shape of the alignment section protrusion may match the cross-sectional shape of the holder central opening. Alternatively, the alignment section protrusion may have a cross-sectional shape individually selected from the group comprising a circle, an ellipse, and a simple (regular) polygon, wherein the sides of the polygon may be straight orcurved. Yet, the cross-sectional shape of the alignment section protrusion may be smaller than the cross-sectional shape of the holder central opening. That is, after insertion of the insert into the holder, the alignment section protrusion may span < 100%, such as < 99%, especially < 95%, of a distance between opposite sides of the holder central opening in any direction. Additionally or alternatively, after insertion of the insert into the holder, the alignment section protrusion may span > 70%, such as > 80%, especially > 90%, of the distance between opposite sides of the holder central opening in any direction.
[0028] The alignment section may further comprise an alignment element. The alignment element may be configured to interact with the alignment means (of the holder). Hence, in embodiments, the holder central opening may be the alignment means, wherein the alignment section protrusion may be the alignment element (and wherein the alignment section protrusion may have an asymmetrical shape). Alternatively, the alignment means may comprise (such as be) the alignment protrusion, wherein the alignment element may comprise (such as be) an alignment cavity (or through opening). Alternatively, the alignment means may comprise (such as be) the alignment cavity, wherein the alignment element may comprise (such as be) an alignment protrusion. That is, the alignment element may be complementary to the alignment means. The alignment section may comprise a plurality of alignment elements. In embodiments, the alignment section may comprise the same number of alignment elements as the number of alignment means in the holder (lid). Alternatively, the number of alignment elements may be individually selected from the range of 1-6, such as from the range of 2-5, especially from the range of 3-4.
[0029] The insert may further comprise the tubular element. The tubular element may be configured intersecting with the alignment section (i.e., the tubular element may extend or pass through the alignment section). Further, the tubular element may (partially) extend from the alignment section at an alignment section first face. Especially, the alignment section protrusion may comprise the alignment section first face, such that (during use of the module) the tubular element may (partially) extend into the holder (cup). The tubular element may comprise a tubular element first end. Especially, the tubular element first end may be configured to extend into the holder (during use of the module and / or of the measurement system). The tubular element may have a first internal (equivalent circular) diameter (Di) at the tubular element first end. In embodiments, the first internal diameter (Di) may be selected from the range of > 0.7 mm, such as from the range of > 1.0 mm, especially from the range of > 1.3 mm. Additionally or alternatively, the first internal diameter (Di) may be selected from the range of < 2.3 mm, such as from the range of < 2.0 mm, especially from the range of < 1.8mm. Hence, in embodiments, 0.7 mm < Di < 2.3 mm, such as 1.0 mm < Di < 2.0 mm, especially 1.3 mm < Di < 1.8 mm.
[0030] Further, the tubular element may comprise a tubular element second end. The tubular element second end may especially be configured opposite the tubular element first end. Further, the tubular element may have a second internal (equivalent circular) diameter (D2) at the tubular element second end. In embodiments, the second internal diameter (D2) may be selected from the range of > 2.3 mm, such as from the range of > 2.5 mm, especially from the range of > 2.7 mm. Additionally or alternatively, the second internal diameter (D2) may be selected from the range of < 3.7 mm, such as from the range of < 3.5 mm, especially from the range of < 3.3 mm. Hence, in embodiments, 2.3 mm < D2 < 3.7 mm, such as 2.5 mm < D2 < 3.5 mm, especially 2.7 mm < D2 < 3.3 mm. Further, in embodiments, D2 > Di may apply, such as D2 - Di > 0.2 mm, especially D2 - Di > 0.5 mm, like D2 - Di > 0.8 mm. Additionally or alternatively, D2 - Di < 1.4 mm may apply, such as D2 - Di < 1.2 mm, especially D2 - Di < 1.0 mm.
[0031] The tubular element may have the central axis (AT) perpendicular to the second internal diameter (D2) (and to the first internal diameter (Di)). The central axis (AT) may intersect a geometrical center of the tubular element (and of the insert). Especially, the central axis (AT) may indicate a length axis of the tubular element. The tubular element may have a cross-sectional shape perpendicular to the central axis (AT), selected from the group comprising a circle, an ellipse, and a simple (regular) polygon, wherein the sides of the polygon may be straight or curved. Especially, the tubular element may have a circular shape (in the crosssection perpendicular to the central axis (AT), and along > 80%, such as along > 90%, especially along > 95%, including along 100%, of the tubular element), wherein the cental axis (AT) may intersect a center of the circular shape.
[0032] Returning to the tubular element first end, the tubular element first end may comprise one or more first end protrusions. The one or more first end protrusions may especially be configured extending from the tubular element in a direction parallel to the first internal diameter (Di) (and perpendicular to the central axis (AT)). The one or more first end protrusions may be configured to support the cardiac chamber model (during use of the model and / or of the measurement system). The one or more first end protrusions may have a protrusion height (Hp) parallel to the central axis (AT). In embodiments, the protrusion height (Hp) may be selected from the range of > 0.02 mm, such as from the range of > 0.05 mm, especially from the range of > 0.1 mm. Additionally or alternatively, the protrusion height (Hp) may be selected from the range of < 1 mm, such as from the range of < 0.8 mm, especiallyfrom the range of < 0.5 mm. Hence, 0.02 mm < Hp< 1 mm may apply, such as 0.05 mm < Hp< 0.8 mm, especially 0.1 mm < Hp< 0.5 mm. The protrusion height Hpmay be constant over the one or more first end protrusions. Alternatively, the protrusion height Hpmay decrease along the protrusion width (Wp) (see below) (and with increasing distance from the (center of the) tubular element).
[0033] Further, the one or more first end protrusions may have a protrusion shape in a cross-section perpendicular to the central axis (AT). In embodiments, the protrusion shape of each of the one or more first end protrusions may be a (rounded) rectangle, a circular sector (e.g. a semi-circle), or an elliptical sector (e.g. a semi-ellipse). In such embodiments, the tubular element first end may especially comprise > 1, such as > 2, especially > 3, first end protrusions. Additionally or alternatively, the tubular element first end may comprise < 6, such as < 5, especially < 4, first end protrusions. Yet, in embodiments, the tubular element first end may comprise a (single) first end protrusion. The (single) first end protrusion may form a continuous protrusion around the circumference of the tubular element. In such embodiments, the protrusion shape may especially be an annulus. That is, the one or more first end protrusions may comprise a protruding disc. The one or more first end protrusions, such as especially the protruding disc, may be configured protruding from the tubular element first end (in a direction perpendicular to the central axis (AT)) by a protrusion width (Wp). In embodiments, Wp> 0.01 mm may apply, such as Wp> 0.05 mm, especially Wp> 0.1 mm. Additionally or alternatively, Wp< 0.7 mm may apply, such as Wp< 0.5 mm, especially Wp< 0.3 mm. Hence, the protrusion width (Wp) may be selected from the range of 0.01-0.7 mm, such as from the range of 0.05-0.5 mm, especially from the range of 0.1 -0.3 mm. Hence, in specific embodiments, the one or more first end protrusions may comprise a protruding disc, wherein the protruding disc may be configured protruding from the tubular element first end by a protrusion width (Wp), and wherein the protrusion width (Wp) may be selected from the range of 0.05-0.5 mm. A protruding disc may provide support for the cardiac chamber model around a full circumference of the tubular element. Hence, such a protruding disc may reduce the chance of detachment of the cardiac chamber model from the tubular element during measurements.
[0034] The alignment section may comprise an alignment section second face. The alignment section second face may especially be configured opposite the alignment section first face. Further, the tubular element second end may be configured at a side of the alignment section second face. In embodiments, the alignment section second face may comprise the tubular element second end. Alternatively, the tubular element may be configured extending from the alignment section at the alignment section second face, wherein the tubular elementsecond end may be configured at a side of the alignment section second face (i.e., the tubular element second end may be configured closer to the alignment section second face than to the alignment section first face). Hence, in specific embodiments, the tubular element may further be configured extending from the alignment section at an alignment section second face opposite the alignment section first face.
[0035] The tubular element may comprise a tubular element top section. The tubular element top section may comprise (such as end in) the tubular element second end. Would the tubular element be configured extending from the alignment section second face, the tubular element top section may especially be the section of the tubular element extending from the alignment section second face. Alternatively, the tubular element top section may be configured intersecting the alignment section. The tubular element top section may have a second length (L2) perpendicular to the second interna diameter (D2) and parallel to the center axis (AT). In embodiments, the L2 > 2.5 mm may apply, such as L2 > 3 mm, especially L2 > 4 mm, like L2 > 6 mm. Additionally or alternatively, L2 < 20 mm may apply, such as L2 < 18 mm, especially L2 < 16 mm. The tubular element top section may have a constant internal diameter along the tubular element top section. That is, over the second length (L2), the second internal diameter (D2) may deviate < 15%, such as < 10%, especially < 5%, like < 2%, including 0% (compared to an average second internal diameter (D2) over the second length (L2)). Hence, in specific embodiments, the alignment section may comprise an alignment section second face opposite the alignment section first face; wherein the tubular element second end may be configured at a side of the alignment section second face; wherein the tubular element may comprise a tubular element top section; wherein the tubular element top section may have a second length (L2), wherein L2 > 4 mm; and wherein the second internal diameter (D2) may deviate < 10% over the second length (L2). A constant second internal diameter (D2) may facilitate that a change in fluid (level) height in the tubular element top section may linearly correlate to a change in (fluid) volume in the tubular element top section, thereby allowing for a relatively simple correlation between a change in fluid (level) height and e.g. a ejection fraction of the cardiac chamber model.
[0036] As indicated above, the tubular element top section may be configured extending from the alignment section second face. In such embodiments, the tubular element top section may comprise one or more, such as especially a plurality of, (fluid) level marks configured around (at least part of) an outer circumference of the tubular element top section. The plurality of (fluid) level marks may be configured evenly distributed along the second length (L2). Especially, a (mutual) distance between neighboring (fluid) level marks may beselected such, that the distance between two neighboring (fluid) level marks may correspond to a discrete and known (change in) volume inside the tubular element top section. That is, the (fluid) level marks may act as scale markings.
[0037] The tubular element may further comprise a tubular element middle section. The tubular element middle section may be configured intersecting the alignment section. Further, the tubular element middle section may be configured between the alignment section first face and the alignment section second face. The tubular element middle section may have a third internal diameter (D3) at the alignment section first face. In embodiments, D3 > 0.9*Di may apply, such as D3 > 0.95*Di, especially D3 > 0.98*Di. Additionally or alternatively, D3 < 1.1 *Di may apply, such as D3 < 1.05*Di, especially D3 < 1.02*Di. Hence, 0.9*Di < D3 < 1.1 *Di may apply, such as 0.95*Di < D3 < 1.05*Di, especially 0.98*Di < D3 < 1.02*Di. Further, the tubular element middle section may comprise a middle section second end opposite the alignment section first face. In embodiments, the tubular element top section may be configured extending from the alignment section second face, such that the middle section second end may be configured at the alignment section second face. Alternatively, the tubular element may have a third length (L3) parallel to the central axis (AT) and between the alignment section first face and the tubular element second end, wherein the middle section second end may be configured at a height of L3 - L2 from the alignment section first face. Yet, in specific embodiments, the tubular element middle section may comprise the tubular element top section, and the tubular element second end may comprise, such as be, the middle section second end. The tubular element middle section may have a fourth internal diameter (D4) at the middle section second end. In embodiments, D4 > 0.9*D2 may apply, such as D4 > 0.95*D2, especially D4 > 0.98*D2. Additionally or alternatively, D4 < 1.1 *D2 may apply, such as D4 < 1.05*D2, especially D4 < 1.02*D2. Hence, 0.9*D2 < D4 < 1.1 *D2 may apply, such as 0.95*D2 < D4 < 1.05*D2, especially 0.98*D2 < D4 < 1.02*D2. Further, an internal diameter of the tubular element middle section may taper from D4 to D3 along the tubular element middle section. The tubular element middle section may, for instance, be shaped as a truncated cone. Hence, in specific embodiments, the tubular element may comprise a tubular element middle section, wherein the tubular element middle section may be configured intersecting the alignment section, wherein the tubular element middle section may have a third internal diameter (D3) at the alignment section first face, and a fourth internal diameter (D4) at a middle section second end opposite the alignment section first face, wherein 0.95*Di < D3 < 1.05*Di and 0.95*D2 < D4 < 1.05*D2, and wherein an internal diameter of the tubular element middle section may taper from D4 to D3 along the tubular element middle section. Such a tubular element middlesection may facilitate that an internal diameter at the tubular element first end may be relatively smaller than an internal diameter at the tubular element second end, wherein the internal diameter may gradually decrease along the tubular element middle section.
[0038] The module may further comprise a module lid. The module lid may be configured to (during use of the module and / or the measurement system) at least partially cover the holder cup and the holder lid. That is, the holder lid and / or holder cup may be configured to (at least partially) support the module lid. The module lid may comprise a first module lid opening. The first module lid opening may be configured to host part of the tubular element (and optionally part of the alignment section). That is, the tubular element (and optionally part of the alignment section) may be configured partially extending through the first module lid opening. Especially, the tubular element may comprise the tubular element top section configured extending from the alignment section second face, wherein the tubular element top section may be configured partially extending through the first module lid opening. Alternatively, the alignment section second face may comprise (or be level with) the tubular element second end, wherein the tubular element and alignment section may be configured partially extending through the first module lid opening. The shape of the first module lid opening may match the shape of the tubular element and / or alignment section configured partially extending through the first module lid opening, wherein an (inside) edge of the first module lid opening may be configured at a distance of 0.01-3 mm, such as 0.05-2 mm, especially 0.1-1 mm, from a closest edge of the tubular element and / or alignment section configured partially extending through the first module lid opening. Hence, in specific embodiments, the module may further comprise a module lid, wherein the module lid may be configured to at least partially cover the holder cup and the holder lid, wherein the module lid may comprise a first module lid opening; and wherein the tubular element may be configured partially extending through the first module lid opening. Such a module lid may protect the holder cup, holder lid, and / or insert against damage and / or ingress.
[0039] The module lid may further comprise a second module lid opening. Especially, (viewing the module) along a direction of (i.e., parallel to) the central axis (AT), the second module lid opening may be configured aligned with the lid opening. Further, the second module lid opening may have a (cross-sectional) shape and size (perpendicular to the central axis (AT)) matching the (cross-sectional) shape and size of the lid opening (perpendicular to the central axis (AT)). Further, the module lid may comprise a plurality of second module lid openings, wherein the number of second module lid openings may match the number of lid openings in the holder lid. Hence, in specific embodiments, the module lid may further comprise a secondmodule lid opening, wherein, along a direction of the central axis (AT), the second module lid opening may be configured aligned with the lid opening. Such a second module lid opening may allow for access to the (inside of the) holder cup after placement of the module lid, such that e.g. (further) electrodes may be placed into the holder cup and / or drugs may be administered to the cardiac chamber model.
[0040] The measurement system may further comprise a distance sensor. The distance sensor may especially be a non-invasive distance sensor. Further, the distance sensor may be configured to determine a distance to a fluid (level) in the tubular element (especially in the tubular element top section and / or in the tubular element middle section) by emitting a sensor signal to (an inside of) the tubular element. The distance sensor may (be configured to) emit the sensor signal along a first axis (Ai). The first axis (Ai) may be configured at a first angle (ai) with the central axis (AT). In embodiments, oil < 30° may apply, such as oil < 20°, especially on < 10°, like ai < 5°, including ai = 0°. Hence, the first axis (Ai) and the central axis (AT) may be parallel. Further, the first axis (Ai) may intersect the central axis (AT) at one or more points along an inside of the tubular element (such as especially at one or more points along the second length (L2)). That is, the first axis (Ai) may at least partially pass through an inside of the tubular element.
[0041] The sensor signal may be selected from the group comprising an optical signal, an electrical signal, a (radio-frequency) electromagnetic signal, and an acoustic signal. The acoustic sensor may have a frequency selected from the range of 50 Hz to 2 MHz, such as from the range of 100 Hz to 1 MHz, especially from the range of 1 kHz to 1 MHz, though lower and higher frequencies are herein not excluded. The electromagnetic wave of the (radio-frequency) electromagnetic signal may have a wavelength selected from the range of > 1 mm, such as from the range of > 2 mm, especially from the range of > 3 mm. Additionally or alternatively, the (radio-frequency) electromagnetic signal may have a frequency selected from the range of 30 Hz to 300 GHz, such as from the range of 1 kHz to 300 GHz, especially from the range of 1 GHz to 300 GHz. The optical signal may comprise light having one or more wavelengths selected from the range of 190-1500 nm, such as from the range of 200-1200 nm, especially from the range of 250-900 nm, like from the range of 380-780 nm. Hence, the distance sensor may be configured to emit one or more of radiation, radio waves, and sound, and / or the distance sensor may be configured to generate an electrical field. That is, the distance sensor may comprise one or more of an optical sensor, a capacitive sensor, and an acoustic sensor. In specific embodiments, the distance sensor may comprise (such as be) an optical sensor, wherein the sensor signal comprises an optical signal. An optical sensor may be especially non-invasive. Further, an optical sensor may be relatively accurate in detecting and / or relatively sensitive to (changes in) a fluid (level) height.
[0042] Hence, the distance sensor may comprise, such as be, an optical sensor. The optical sensor may be selected from the group comprising a confocal sensor, a time of flight sensor, a laser triangulation sensor, an intensity modulation sensor, an interferometry sensor, a Fiber-Bragg-grating-based sensor, and an infrared sensor. Especially, the optical sensor may comprise a confocal sensor. The confocal sensor may comprise a confocal controller and an optical displacement sensor. The confocal controller may be configured to control one or more of an intensity, (spatial) spectral power distribution (along the first axis (Ai)), and measuring rate of the optical signal. Further, the optical displacement sensor may be configured to provide the optical signal to the module (especially to the tubular element), and to receive a reflected optical signal from the module (especially from liquid in the tubular element). In embodiments, a spectral power distribution of the optical signal (from the confocal sensor) may change along the first axis (Ai). That is, at a first point along the first axis (Ai), the optical signal may have a first spectral power distribution, while at a second point along the first axis (Ai), the optical signal may have a second spectral power distribution, wherein the first and second spectral power distributions may differ. Especially, the confocal sensor may be configured to provide, at each point along the first axis (Ai) until a focal point of the optical signal, monochromatic radiation, wherein the wavelength of the monochromatic radiation may differ at each point along the first axis (Ai) (until the focal point of the optical signal). In such embodiments, each wavelength may be assigned to a specific distance, such that a wavelength of the reflected optical signal (reflected by the fluid in the tubular element) may be (directly) correlated to a distance between (a light-emitting face of) the confocal sensor and the fluid level.
[0043] The optical signal (from the confocal sensor) may comprise a converging (or focusing) beam of light. Hence, a beam diameter (DB) (in units mm) of the optical signal may decrease with increasing distance from the confocal sensor. The beam diameter (DB) may be determined by a full width at 10% of the maximum of the optical signal. Especially, the confocal sensor (and module) may be configured such, that, at the tubular element second end, the beam diameter (DB) of the optical signal may be < D2. Further, at the tubular element second end, DB < 0.98*D2 may apply, such as DB < 0.95*D2, especially DB < 0.9*D2. Additionally or alternatively, at the tubular element second end, DB > 0.3*D2 may apply, such as DB > 0.4*D2, especially DB > 0.5*D2. Hence, the optical signal may enter the tubular element, wherein relatively little (< 10%, such as < 5%) of the optical signal may be incident on a wall of the tubular element. Further, a focal point of the optical signal may be configured inside the tubularelement and at a distance of < L2, such as < 0.95*L2, especially < 0.9*L2, from the tubular element second end. Additionally or alternatively, the focal point of the optical signal may be configured inside the tubular element and at a distance of > 0.5*L2, such as > 0.6*L2, especially > 0.7*L2, from the tubular element second end. Alternatively, the tubular element middle section may comprise the tubular element top section, wherein the focal point of the optical signal may be configured inside the tubular element and at a distance of < L3, such as < 0.95 *L ;, especially < 0.9*L;, from the middle section second end. Additionally or alternatively, the focal point of the optical signal may be configured inside the tubular element and at a distance of > 0.5*L3, such as > 0.6*L3, especially > 0.7*L3, from the middle section second end. Additionally or alternatively, the focal point of the optical signal may be configured inside the tubular element and at a distance of < 12 mm, such as < 10 mm, especially < 8 mm, from the tubular element second end. Additionally or alternatively, the focal point of the optical signal may be configured inside the tubular element and at a distance of > 0.5 mm, such as > 1 mm, especially > 2 mm, from the tubular element second end. In embodiments, the confocal sensor may be configured to determine a distance to any point located between a light-emitting face of the confocal sensor and the focal point of the optical signal. Hence, the focal point may indicate an extreme of the measurement range of the confocal sensor.
[0044] Hence, the distance sensor (e.g. the optical sensor or confocal sensor) may be configured to determine a distance to a fluid (level) in the tubular element (by reflection of the sensor signal at a surface of the fluid). Further, the distance sensor may be configured to provide a (related) distance signal to the control system. Hence, the measurement system may comprise a control system. The control system may be configured to control the distance sensor (such as the confocal controller and / or the optical displacement sensor). Further, the control system may be configured to receive the distance signal from the distance sensor. Especially, the control system may be configured to determine the cardiac functional parameter based on the distance signal (and optionally the sensor signal). In embodiments, the fluid may be configured to alter one or more properties of the sensor signal (upon reflection), wherein the distance signal may comprise an altered sensor signal, and wherein the control system may be configured to determine the cardiac functional parameter by comparing the distance signal to the sensor signal. Alternatively, the control system (and / or the distance sensor) may emit a pulsed sensor signal, wherein the distance signal may comprise a time between emission of (a single pulse of) the sensor signal and reception of a reflected sensor signal, and wherein the control system may be configured to determine the cardiac functional parameter based on this time. Alternatively, such as in the case the distance sensor comprises the confocal sensor, thefluid may be configured to reflect only radiation with a specific wavelength (wherein the wavelength may be determined by the distance between the confocal sensor and the fluid), wherein the distance signal comprises radiation with a specific wavelength, and wherein the control system may be configured to determine the cardiac functional parameter by determining the wavelength of the distance signal (and comparing the wavelength to a table describing the correlation between the wavelength of the reflected signal and the distance).
[0045] The term “controlling” and similar terms especially refer at least to determining the behavior or supervising the running of an element. Hence, herein “controlling” and similar terms may e.g. refer to imposing behavior on the element, such as e.g. measuring, displaying, actuating, opening, shifting, changing temperature, etc.. Beyond that, the term “controlling” may additionally include monitoring. The controlling of the element can be done with a controller, which may also be indicated as “control system”. The controller and the element may thus at least temporarily, or permanently, functionally be coupled. The element may comprise the controller. The controller and element may be physically separated. Control can be done via wired and / or wireless control. The term “controller” may also refer to a plurality of different controllers, which may be functionally coupled, and of which e.g. one controller may be a master controller and one or more others may be slave controllers. A controller may comprise or may be functionally coupled to a user interface. The controller may be configured to receive and execute instructions from a remote control. The controller may be controlled via an App on a (remote) device, such as a portable device, like a smartphone, a tablet, etc.. The device is thus not necessarily coupled to the control system, but may be (temporarily) functionally coupled to the control system. Would the controller be controlled by an App on a remote device, the controller may control in a slave mode.
[0046] The measurement system may further comprise a second sensor. The second sensor may be configured to determine a first (largest) area (Aci) of the cardiac chamber model in a first cross-section of the cardiac chamber model parallel to the central axis (AT). Additionally or alternatively, the second sensor may be configured to determine a second (largest) area (Aci) of the cardiac chamber model in a second cross-section of the cardiac chamber model perpendicular to the central axis (AT). Especially, the cardiac chamber model may have a first largest circumference parallel to the central axis (AT), and a second largest circumference perpendicular to the central axis (AT), wherein the second sensor may be configured to detect an area of the projection of (the cardiac chamber model having) the first and / or second largest circumference (on a plane parallel to a second sensor face configured to receive a (second sensor) signal). Further, the second sensor may be configured to provide arelated second sensor signal to the control system. Especially, the control system may be configured to determine the cardiac functional parameter based on the distance signal and the second sensor signal. Hence, in specific embodiments, the measurement system may further comprise a second sensor, wherein the second sensor may be configured to determine one or more of: (i) a first area (Am) of the cardiac chamber model in a first cross-section of the cardiac chamber model parallel to the central axis (AT), and (ii) a second area (Aci) of the cardiac chamber model in a second cross-section of the cardiac chamber model perpendicular to the central axis (AT); wherein the second sensor may be configured to provide a related second sensor signal to the control system, and wherein the control system may be configured to determine the cardiac functional parameter based on the distance signal and the second sensor signal. Such a second sensor may provide additional information regarding the cardiac chamber model to the control system, thereby allowing the control system to determine different or a larger number of cardiac functional parameters. Especially, using the first and / or second area, the control system may be configured to determine a contraction state of the cardiac chamber model (over time) (wherein a stronger contraction may result in a smaller area). Additionally or alternatively, using the first and / or second area, the control system may be configured to estimate a volume of the heart, wherein the control system may be configured to determine an ejection fraction based on the volume (over time) and the (change in) distance (over time).
[0047] The second sensor may thus be configured to determine a(n) (cross-sectional) area of the cardiac chamber model. In embodiments, the second sensor may be an acoustic sensor, wherein the second sensor may be configured to determine the area by emitting (and receiving) a (reflected) acoustic signal. Alternatively, the second sensor may be an optical sensor. In specific embodiments, the second sensor may comprise a camera. Hence, the second sensor may be configured to record one or more images of the cardiac chamber model, wherein the second sensor may be configured to determine the first area (Am) and / or the second area (Aci) based on the one or more images. The second sensor signal may be configured to derive a numerical value for the first area (Am) and / or second area (Ac2) from the one or more images, wherein the second sensor signal may comprise the numerical value. Alternatively, the second sensor signal may comprise the one or more images, wherein the control system may be configured to derive (the numerical value for) the first area (Am) and / or second area (Ac2) from the one or more images. The first area (Am) and / or second area (Ac2) may especially provide information regarding (a change in) the shape of the cardiac chamber model (over time), wherein the shape may e.g. change due contraction of the cardiac chamber model.The second sensor may be configured to continuously provide the related second sensor signal to the control system (during the measurement). Alternatively, the measurement system may be configured to record one or more images with the second sensor during a first time period, wherein the second sensor may be configured to provide the related second sensor signal to the control system during a second (later) time period (or at a second (later) time point), chronologically separated from the first time period. In such embodiments, the second sensor signal may further comprise an identifier or time stamp for each of the one or more images, such that the control system may correlate the second sensor signal to the (simultaneously recorded) distance signal.
[0048] The second sensor may comprise a primary second sensor and a secondary second sensor. The primary second sensor may be the same as the secondary second sensor. Alternatively, the primary second sensor and the secondary second sensor may differ. Yet, each of the primary second sensor and the secondary second sensor may comprise a camera (wherein the cameras may optionally differ in one or more of resolution, frame rate, and sensitivity). Further, the primary second sensor may be configured to determine the first (largest) area (Aci). Additionally, the secondary second sensor may be configured to determine the second (largest) area (Aci). In embodiments, the camera of the (primary, and optionally secondary) second sensor may have a bit depth (i.e., a number of bits used to define each pixel) of > 4, such as > 8, especially > 10 bit. Further, in embodiments, the camera of the (primary, and optionally secondary) second sensor may have a frame rate of > 20 fps, such as > 40 fps, especially > 50 fps, like > 80 fps. Additionally or alternatively, the camera of the (primary, and optionally secondary) second sensor may have a read noise (i.e., the noise that may be produced during the transfer of charge from the pixels to the camera) of < 1.2 e", such as < 1 e", especially < 0.8 e . Hence, in specific embodiments, the second sensor may comprise a primary second sensor and a secondary second sensor, wherein the primary second sensor may be configured to determine the first area (Aci), and wherein the secondary second sensor may be configured to determine the second area (Aci)- The measurement system may further comprise a heating element. In embodiments, the measurement system may comprise a platform configured to host and / or support the module (see below), wherein the platform may comprise the heating element. Alternatively, the heating element may be (configured as) a separate element. The heating element may be configured in thermal contact with the module. Alternatively, the heating element may be configured to provide heat to the module through convection. Especially, theheating element may be configured to maintain a temperature of the cardiac chamber module in a range of 30-43 °C, such as in a range of 33-39 °C, especially in a range of 35-38 °C.
[0049] The measurement system may further comprise a thermal sensor (e.g. a thermometer). The thermal sensor may be configured to monitor a(n internal) temperature of the holder cup (such as especially of the cardiac chamber model). Further, the thermal sensor may be configured to provide a related thermal signal to the control system. The control system may be configured to control the heating element based on the thermal signal.
[0050] In embodiments, the measurement system may comprise a plurality of modules arranged in a first array. Such a first array may facilitate measuring a cardiac functional parameter from a plurality of cardiac chamber models (simultaneously or) sequentially, wherein the plurality of cardiac chamber models may have a fixed location with respect to each other (thereby allowing automatization). The first array may especially be a regular n*m array, wherein n and m may be individually selected from the range of 1-6, such as from the range of 1-5, especially from the range of 1-4, and wherein n + m > 3 may apply. Hence, the measurement system may comprise 2-48, such as 2-36, especially 4-24, like 8-16, modules arranged in the first array. The plurality of modules may be configured at least partially physically coupled in the first array (via their respective holder cups). Especially, the holder cups of the plurality of modules may foim a monolithic element. Further, the module lids of the plurality of modules may foim a monolithic element. Optionally, the holder lids of the plurality of modules may form a monolithic element. Yet, especially, the holder lids may be configured as separate elements.
[0051] Further, the cup bases of the holder cups of the plurality of modules may form a monolithic element. Hence, would each of the cup bases comprise one or more electrodes, the electrodes from the plurality of holder cups may be arranged in an array (in the monolithic element). That is, the cup bases of (the holder cups of) the plurality of modules may form a monolithic (and planar) element, wherein the electrodes from the plurality of modules may be arranged in an array in the monolithic element. The monolithic element (formed by the cup bases) may further comprise the electrical tracks of the holder cups. Especially, the monolithic element may comprise the electrically insulating material, with the electrodes and electrical tracks arranged on the electrically insulating material (e.g. as printed electrodes and printed electrical tracks). For each holder cup may apply that each of the electrical tracks may have a connection point configured to electrically couple the electrical track to a power source, wherein the connection points of the holder cups may be arranged in clusters or arrays on the monolithic element (e.g. towards the side of the monolithic element). Such a configuration mayallow for easy and simultaneous electrical coupling of the holder cups in the first array. In embodiments, the cup walls of the holder cups of the plurality of modules may foim a monolithic element. As such, the holder cups of the plurality of modules in the first array may be formed by combining the monolithic element comprising the cup bases and the monolithic element comprising the cup walls.
[0052] The measurement system may further comprise a movement element. The movement element may be configured to control a position of the distance sensor relative to the (plurality of) module(s). The movement element may be configured to control a position of the distance sensor, wherein the movement element may comprise a holder configured to host the distance sensor (such as especially the optical displacement sensor). Additionally or alternatively, the movement element may be configured to control a position of the (plurality of) module(s). In such embodiments, the movement element may comprise a platform, wherein the platform may be configured to host and / or support the (plurality of) module(s). The platform may comprise one or more fixating elements, wherein the one or more fixating elements may be configured to fixate a position of the (plurality of) module(s) on the platform. The platform may comprise a transparent section or through opening along the first axis (Ai) and / or central axis (AT) (of the module being measured), wherein the second sensor may be configured to deteimine the second (largest) area (Aci) through the transparent section or through an opening. In embodiments, the control system may be configured to control the movement element. Hence, in specific embodiments, the measurement system may comprise a plurality of modules arranged in a first array, wherein the measurement system may further comprise a movement element, wherein the movement element may be configured to control a position of the distance sensor relative to the plurality of modules, and wherein the control system may be configured to control the movement element. Such a first array may facilitate measuring a cardiac functional parameter from a plurality of cardiac chamber models (simultaneously or) sequentially. Further, such a movement element may facilitate aligning each tubular element with the distance sensor automatically.
[0053] The measurement system may be used to measure a cardiac functional parameter (from a cardiac chamber model). The cardiac functional parameter may comprise an ejection fraction. The term “ejection fraction” may refer to a percentage of the total amount of fluid in the cardiac chamber model that may be pumped out with a (or each) single pumping action of the cardiac chamber model. Additionally or alternatively, the cardiac functional parameter may comprise a stroke volume. The term “stroke volume” may refer to the volume of fluid pumped out of the cardiac chamber model with a single pumping action. Additionallyor alternatively, the cardiac functional parameter may comprise a stroke work. The term “stroke work” may refer to the work done by the cardiac chamber model to eject a volume of fluid (i.e., the stroke volume) from the cardiac chamber model. Additionally or alternatively, the cardiac functional parameter may comprise a pressure inside the cardiac chamber model. Additionally or alternatively, the cardiac functional parameter may comprise a beating frequency. The term “beating frequency” may refer to the number of full beating cycles (by the cardiac chamber model) per minute (i.e., the “heart rate” of the cardiac chamber model). Here, the teim “pumping action” may refer to a single cycle of the cardiac chamber model from end-diastole to end-systole (or from peak relaxation to peak contraction). Further, the term “full beating cycle” may refer to a single cycle of the cardiac chamber model from end-diastole to end-systole and back to end-diastole (or from peak relaxation to peak contraction and back to peak relaxation). Additionally or alternatively, the cardiac functional parameter may comprise a relaxation parameter. The relaxation parameter may comprise one or more of (i) a time between a maximum contraction state and a maximum relaxation state of the cardiac chamber model (“relaxation time”), (ii) a flow rate of the fluid (into the cardiac chamber model) during relaxation (“relaxation flow rate”), and (iii) a change in the first area (Am) and / or the second area (Aci) between max. contraction and max. relaxation (“relaxation velocity”). Additionally or alternatively, the cardiac functional parameter may comprise a cardiac output. The term “cardiac output” may refer to the product of the beating frequency and the stroke volume. Hence, in specific embodiments, the cardiac functional parameter may comprise one or more of an ejection fraction, a stroke volume, a stroke work, a pressure inside the cardiac chamber model, a beating frequency, a relaxation parameter, and a cardiac output. Such cardiac functional parameter(s) may be relevant indicators of the health and / or stress levels of the cardiac chamber model. Further, such cardiac functional parameter(s) may be relevant for clinical testing of drugs.
[0054] According to a further aspect, the invention may provide a measurement method for measuring a cardiac functional parameter of a cardiac chamber model. The measurement method may comprise providing a cardiac model. Especially, the cardiac model may comprise the cardiac chamber model supported by a tubular element. The tubular element may be the tubular element as defined above. Hence, the tubular element may have a (or the) first internal (equivalent circular) diameter (Di) at a tubular element first end, wherein 0.7 mm < Di < 2.3 mm, such as 1.0 mm < Di < 2.0 mm. Further, the tubular element may have a (or the) second internal (equivalent circular) diameter (D2) at a tubular element second end opposite the tubular element first end, wherein optionally 2.3 mm < D2 < 3.7 mm, such as 2.5 mm < D2 < 3.5 mm.The tubular element first end may comprise one or more first end protrusions (as defined above). Especially, the one or more first end protrusions may be configured to support the cardiac chamber model. The measurement method may comprise providing (with a distance sensor) a sensor signal to the cardiac model along a first axis (Ai) (as defined above). Further, the measurement method may comprise determining a distance to a fluid (level) in the tubular element, and providing a (related) distance signal to a control system (as defined above). The measurement method may optically comprise determining a change in fluid level over time in the tubular element based on the distance signal (and the sensor signal). Further, the measurement method may comprise determining the cardiac functional parameter based on the distance signal (such as especially based on the change in fluid level over time). Hence, in specific embodiments, the invention provides a measurement method for measuring a cardiac functional parameter of a cardiac chamber model, wherein the measurement method comprises: (A) providing a cardiac model, wherein the cardiac model comprises the cardiac chamber model supported by a tubular element, wherein the tubular element has a first internal diameter (Di) at a tubular element first end, wherein 1.0 mm < Di < 2.0 mm; wherein the tubular element has a second internal diameter (D2) at a tubular element second end opposite the tubular element first end, (wherein 2.5 mm < D2 < 3.5 mm;) wherein the tubular element first end comprises one or more first end protrusions; wherein the one or more first end protrusions are configured to support the cardiac chamber model; (B) providing a sensor signal to the cardiac model along a first axis (Ai); (C) determining a distance to a fluid in the tubular element, and providing a distance signal to a control system; and (D) determining the cardiac functional parameter based on the distance signal. Such a measurement method may especially be non-invasive, and may thus avoid side-effects of invasive approaches. Hence, such a measurement method may provide a more accurate representation of a (human) heart or cardiac chamber. Further, such a non-invasive measurement method may allow re-using of the cardiac chamber model.
[0055] The measurement method may especially be executed using the measurement system as defined above. Hence, many embodiments related to the measurement method have already been described in relation to the measurement system as defined above. Embodiment relating to the measurement system may apply, mutatis mutandis, to the measurement method for measuring a cardiac functional parameter of a cardiac chamber model.
[0056] The measurement method may comprise providing the cardiac model. The cardiac model may comprise the tubular element as defined above. Especially, the cardiac model may comprise the (holder and) insert as defined above. Further, the cardiac model maycomprise the module as defined above. The cardiac model may further comprise a cardiac chamber model, wherein the cardiac chamber model may be supported by the tubular element, such as especially be the one or more first end protrusions. The cardiac chamber model may comprise a chamber cavity and a chamber opening (see also below). Especially, the chamber cavity may be configured fluidically coupled with the tubular element via the chamber opening. Further, the chamber opening may be configured enclosing the tubular element (near the tubular element first end).
[0057] The measurement method may comprise providing a sensor signal to the cardiac model along a first axis (Ai). The sensor signal may especially be the sensor signal as defined above, and may be provided by or using the distance sensor as defined above. As indicated above, the sensor signal may comprise one or more of an optical signal and an acoustic signal, such as especially an optical signal (comprising a converging beam of light).
[0058] The measurement method may comprise determining a distance to a fluid (level) in the tubular element (with the distance sensor as defined above). Hence, during use of the measurement system, the cardiac chamber model may be configured to host a fluid. Determining the distance to the fluid level may especially comprise emitting a sensor signal to the fluid in the tubular element (with the distance sensor, and) along the first axis (Ai). The sensor signal may comprise a pulsed signal (see above), wherein the measurement method may comprise providing a pulsed sensor signal to the tubular element. Alternatively, the sensor signal may comprise a continuous signal. Further, determining the distance to the fluid level may comprise receiving a reflected sensor signal (with the distance sensor). Additionally, the measurement method may comprise providing a (related) distance signal to a control system (such as the control system defined above).
[0059] The cardiac chamber model may thus be configured to host a fluid. Further, the cardiac chamber model may be configured to contract, thereby altering the fluid level in the tubular element. Hence, the measurement method may comprise repeating a cycle of (a) providing a sensor signal to the cardiac model (along the first axis (Ai)), (b) determining a distance to a fluid (level) in the tubular element, and (c) providing a (related) distance signal to the control system. Especially, the measurement method may at least comprise repeating step (b) with a first frequency (fl) of > 40 Hz, such as > 50 Hz, especially > 60 Hz. In embodiments, the sensor signal may be a continuous signal. Alternatively, the sensor signal may be a pulsed signal, wherein the measurement method may comprise repeating step (a) with the first frequency (fl).Hence, the measurement method may comprise determining the distance to the fluid level with a first frequency (fi). Further, the measurement method may comprise (with the control system) determining a difference between the distance at a first time point and the distance at a second (subsequent) time point (or the distance at any or all subsequent time point). Hence, the measurement method may comprise determining a change in fluid level (in the tubular element). Especially, the measurement method may comprise determining the change in fluid level in the tubular element over time, based on the distance signal (and optionally based on the sensor signal). Further, the measurement method may comprise determining the cardiac functional parameter based on the distance signal. Additionally or alternatively, the measurement method may comprise determining the cardiac functional parameter based on the change in fluid level over time.
[0060] As indicated above, the measurement system may comprise the second sensor, wherein the second sensor may be configured to determine the first area (Aci) and / or the second area (Aci)- Hence, in embodiments, the measurement method may comprise determining the first area (Aci) of the cardiac chamber model in a first cross-section (of the cardiac chamber model) parallel to the first axis (Ai). Additionally or alternatively, the measurement method may comprise determining the second area (Aci) of the cardiac chamber model in a second cross-section (of the cardiac chamber model) perpendicular to the first axis (Ai). Further, the measurement method may comprise repeatedly determining the first area (Aci) and / or second area (Aci)- Additionally, the measurement method may comprise comparing the first area (Aci) and / or second area (Aci) as determined at a first time point with the first area (Aci) and / or second area (Aci) as determined at a second time point. Hence, the measurement method may comprise determining a change in the first area (Aci) and / or second area (Aci)- Further, the measurement method may comprise determining a change over time in the first area (Aci) and / or in the second area (Aci)- Especially, the measurement method may comprise determining the cardiac functional parameter based on the distance signal and the respective (first and / or second) area(s). Further, in embodiments, the measurement method may comprise determining the cardiac functional parameter based on the change in fluid level over time and the change in the respective (first and / or second) area(s) over time. Hence, in specific embodiments, the measurement method further may comprise: (A) determining one or more of (i) a first area (Aci) of the cardiac chamber model in a first cross-section parallel to the first axis (Ai), and (ii) a second area (Aci) of the cardiac chamber model in a second crosssection perpendicular to the first axis (Ai); and (B) determining the cardiac functionalparameter based on the distance signal and the respective area. Such a measurement method may facilitate determining a different or a larger number of cardiac functional paramet er(s).
[0061] As indicated above, the measurement system may comprise a heating element. Hence, in embodiments, the measurement method may comprise maintaining a temperature of the cardiac model, especially of the cardiac chamber model. Especially, the measurement method may comprise maintaining a temperature of the cardiac chamber model in a range of 30-43 °C, such as in a range of 33-39 °C, especially in a range of 35-38 °C.
[0062] The measurement method may further comprise providing a drag or therapeutic to the cardiac chamber model. The drag or therapeutic may be provided to the cardiac chamber model through the lid opening(s) (and the second module lid opening(s)). Especially, in such embodiments, the drag or therapeutic may be provided to a fluid configured in the holder cup and surrounding the cardiac chamber model. Additionally or alternatively, the drag or therapeutic may be provided to (a fluid in) the cardiac chamber model through the tubular element. The drag or therapeutic may be any (experimental) drag or therapeutic known in the art. Especially, the drag or therapeutic may be a drag or therapeutic (suspected of) having an effect on a cardiac functional parameter.
[0063] Additionally or alternatively, the measurement method may comprise providing a(n external) stimulus to the cardiac chamber model. The (external) stimulus may be selected from the group comprising an electrical stimulus, a temperature stimulus, a pressure stimulus, an afterload (i.e., an increase or decrease in the fluidic resistance that the cardiac chamber model may overcome during contraction), hypoxia, an injury to the cardiac chamber model (e.g. a cryoinjury), and a change in the properties or volume of the fluid hosted by the cardiac chamber model (e.g. a preload). Would the (external) stimulus be an electrical stimulus, the measurement method may further comprise providing electrodes, wherein the electrodes may be configured at least partially extending into the holder cup through the lid opening(s) (and the second module lid opening(s)). Yet, alternatively, would the (external) stimulus be an electrical stimulus, the holder cup (such as the cup base) may comprise the one or more electrodes, wherein the measurement method may comprise providing the electrical stimulus with the one or more electrodes. Further, would the (external) stimulus be a change in the properties or volume of the fluid hosted by the cardiac chamber model, the measurement method may comprise one or more of (i) replacing at least part of the fluid hosted by the cardiac chamber model with a different fluid, and (ii) adding fluid to the cardiac chamber model or removing at least part of the fluid hosted by the cardiac chamber model.Additionally or alternatively, the measurement method may comprise mimicking a (cardiac) disease with the cardiac chamber model. In such embodiments, at least part of the cells comprised by the cardiac chamber model may be diseased (e.g. caused by mutations induced in the cells (e.g. through knockout of a gene) or by using at least one diseased first cell (e.g., from a patient stem cell line) while preparing the cardiac chamber model). Alternatively, in such embodiments, the disease may be mimicked (or triggered) through one or more of (i) the addition of one or more of radiation, a chemical agent, mechanical loading, an electrical signal, and a biological agent to the cardiac chamber model, (ii) restricting the uptake of oxygen by the cardiac chamber model (inducing hypoxia), (iii) causing an injury to the cardiac chamber model (e.g. a cryoinjury).
[0064] Hence, the measurement method may comprise one or more of (a) providing a drag or therapeutic to the cardiac chamber model, (b) providing a stimulus to the cardiac chamber model, and (c) mimicking a disease with the cardiac chamber model. Further, the measurement method may comprise determining a first cardiac functional parameter at a first time (ti). Especially, the first time (ti) may correspond to a point in time before addition of the drag, therapeutic, or stimulus. Additionally, the measurement method may comprise determining a second cardiac functional parameter at a second time (t^). The second time (t^) may especially correspond to a point in time after addition of the drag, therapeutic, or stimulus (and optionally after an incubation period). The first time (ti) and the second time (tz) may be chronologically separated by at least 1 second (s), such as at least 2 s, especially at least 3 s. Additionally or alternatively, the first time (ti) and the second time (tz) may be chronologically separated by at most 100 days, such as at most 80 days, especially at most 60 days, like at most 30 days. Alternatively, the measurement method may comprise determining the first cardiac functional parameter from a first cardiac chamber model, and determining the second cardiac functional parameter from a (different) second cardiac chamber model. Especially, the second cardiac chamber model may be under the influence of one or more of a drag, a therapeutic, a stimulus, or a disease. The measurement method may comprise comparing the first cardiac functional parameter with the second cardiac functional parameter (with the control system). Hence, in specific embodiments, the measurement method may comprise one or more of (a) providing a drag or therapeutic to the cardiac chamber model, (b) providing a stimulus to the cardiac chamber model, and (c) mimicking a disease with the cardiac chamber model; wherein the measurement method may further comprise determining a first cardiac functional parameter at a first time (ti), and determining a second cardiac functional parameter at a second time (t^). Such a measurement method may allow testing the effects of one or more of a drag, therapeutic,stimulus, and disease on the cardiac functional parameter. Hence, such a measurement method may be used to test drags or therapeutics for safety and / or effectiveness, particularly in the context of a disease state.
[0065] According to a further aspect, the invention may provide the cardiac model as such. The cardiac model may comprise the module as defined above. Yet, the module may further comprise a fluid and a cardiac chamber model. Especially, the holder may be configured to host (at least part of) the fluid. Further, the cardiac chamber model may be configured at the tubular element first end. Especially, the one or more first end protrusions (of the insert) may be configured to at least partially support the cardiac chamber model. The cardiac chamber model may be configured at least partially submerged in the fluid. Further, the cardiac chamber model may comprise first cells. The first cells may comprise cardiomyocyte-like cells. In embodiments, the cardiac chamber model may have an ovoid shape. Further, the cardiac chamber model may comprise a chamber cavity and a chamber opening. The chamber cavity may be configured to host (part of) the fluid. Further, the chamber cavity may be configured fluidically coupled with the tubular element via the chamber opening. As indicated above, the cardiac chamber model may be configured to contract (either spontaneously or in response to an (electrical) stimulus), thereby altering a fluid level in the tubular element. Hence, in specific embodiments, the invention may provide a cardiac model comprising the module, wherein the module further comprises a fluid and a cardiac chamber model; wherein the holder is configured to host the fluid; wherein: (A) the cardiac chamber model is configured at the tubular element first end, wherein the one or more first end protrusions are configured to at least partially support the cardiac chamber model; wherein the cardiac chamber model is configured at least partially submerged in the fluid; and (B) the cardiac chamber model comprises first cells, wherein the first cells comprise cardiomyocyte-like cells; wherein the cardiac chamber model comprises a chamber cavity and a chamber opening; wherein the chamber cavity is configured to host the fluid; and wherein the chamber cavity is configured fluidically coupled with the tubular element via the chamber opening. Such a cardiac model may be used to mimic a human heart (chamber). Further, such a cardiac model may facilitate the testing of e.g. drags without the need for test animals.
[0066] The module may comprise a fluid. Especially, the holder may be configured to host (at least part of) the fluid, such as especially in the holder cup. Further, the chamber cavity (of the cardiac chamber model) may be configured to host (another part of) the fluid. The fluid may comprise blood. Additionally or alternatively, the fluid may comprise an aqueous solution. In specific embodiments, the fluid may comprise a culture medium (for the first cells).Especially, the fluid may be an aqueous solution. Further, the fluid may comprise a thickening agent, such as one or more thickening agents selected from the group of methyl cellulose, xanthan gum, and gelatin. Additionally or alternatively, the fluid may comprise one or more of transforming growth factor P (TGF- ), endothelin 1 (ET-1), vascular endothelial growth factor (VEGF), a TGF- inhibitor (e.g. 4-[4-(l,3-benzodioxol-5-yl)-5-(2-pyridinyl)-lH-imidazol-2-yl]benzamide (SB431542)), and a nitric oxide (NO) synthase inhibitor. Additionally or alternatively, the fluid may comprise Dulbecco's Modified Eagle Medium (DMEM). Additionally or alternatively, the fluid may comprise one or more of D(+)-glucose, sodium pyruvate, sodium 3-hydroxybutyrate, L-camitine hydrochloride, creatine monohydrate, taurine, phenol red, chemically defined lipid concentrate, GlutaMAX supplement, 1-thioglycerol (a-MTG), insulin-transfemn-selenium ethanolamine (ITS-X), ascorbic acid-2P, penicillin-streptomycin, sodium hydrogen carbonate, sodium hydroxide, bovine serum albumin (BSA), L-triiodothyronine (T3), long R3 (human) insulin-like growth factor-I (IGF-I), dexamethasone, and fibroblast growth factor 2. Additionally or alternatively, the fluid may comprise one or more of copper(II) sulfate (C11SO4), zinc sulfate (ZnSCfl), sodium selenite, ferric citrate, manganese sulfate (MnSCfi), sodium metasilicate (NazSiOs), molybdic acid (ammonium salt), ammonium metavanadate (NH4VO3), nickel sulfate (N1SO4), tin chloride (SnCh), aluminum chloride (AICI3), silver nitrate ( AgNOj), barium acetate (Ba(C2H3O2)2), potassium bromide (KBr), cadmium chloride (CdCh), cobalt chloride (C0CI2), chromium chloride (C1CI3), sodium fluoride (NaF), germanium dioxide (GeCh), potassium iodide (KI), rubidium chloride (RbCl), and zirconyl chloride (ZrOCh).
[0067] The fluid hosted by the holder cup may be the same as the fluid hosted by the chamber cavity. Alternatively the fluid hosted by the holder cup may differ from the fluid hosted by the chamber cavity. Hence, the fluid may comprise a first fluid and a second fluid. Especially, the holder (cup) may be configured to host the first fluid. Further, the chamber cavity may be configured to host the second fluid. The first fluid and the second fluid may differ in one or more of a viscosity, a color, a composition, and a concentration of at least one component. For instance, the second fluid may have a higher viscosity than the first fluid (to better mimic the viscosity of blood). Alternatively, for instance, the second fluid may comprise blood, and the first fluid may comprise an aqueous solution. Hence, in specific embodiments, the fluid may comprise a first fluid and a second fluid, wherein the holder may be configured to host the first fluid, wherein the chamber cavity may be configured to host the second fluid, and wherein the first fluid and second fluid may differ in one or more of a viscosity, a color, a composition, and a concentration of at least one component.The module may further comprise the cardiac chamber module, configured at the tubular element first end and at least partially supported by the one or more first end protrusions. The cardiac chamber model may (during use of the module and / or of the cardiac model) be configured at least partially (such as fully) submerged in the (first) fluid. Further, the cardiac chamber model may comprise first cells. The first cells may especially comprise cardiomyocyte-like cells. In embodiments, the first cells may consist of cardiomyocyte-like cells, such as especially human cardiomyocyte-like cells. Yet, alternatively, the first cells may further comprise secondary cells. The secondary cells may comprise structurally supportive cells, such as one or more of (cardiac) fibroblast(-like) cells, and (smooth) muscle cells. Additionally or alternatively, the secondary cells may comprise functionally supportive cells, such as one or more of epicardial cells, endocardial cells, endothelial cells, macrophages, pacemaker cells, pericytes, immune cells, embryonic stem cells, and IPSC-derived cells. Especially, the secondary cells may comprise (cardiac) fibroblast cells. Such secondary cells may especially provide support to the cardiomyocyte-like cells.
[0068] The cardiac chamber model may further comprise a chamber cavity and a chamber opening. As indicated above, the chamber opening may be configured encircling and in physical contact with the tubular element (near the tubular element first end, such as especially above the one or more first end protrusions). Further, the chamber cavity may be configured fluidically coupled with the tubular element via the chamber opening. The chamber cavity may have a(n internal) cavity volume (Vca). In embodiments, the (internal) cavity volume (Vca) may be selected from the range of > 3 pl, such as from the range of > 5 pl, especially from the range of > 10 pl, like from the range of > 15 pl. Additionally or alternatively, the (internal) cavity volume (Vca) may be selected from the range of < 3 ml, such as from the range of < 2.5 ml, especially from the range of < 2 ml. Further, the (internal) cavity volume (Vca) may be selected from the range of < 500 pl, such as from the range of < 250 pl, especially from the range of < 100 pl, like from the range of < 80 pl. Hence, 3 pl < Vca < 500 pl, such as 5 pl < Vca < 250 pl, especially 10 pl < Vca < 100 pl, like 15 pl < Vca < 80 pl.
[0069] The cardiac chamber model may have a chamber shape in a cross-section of the cardiac chamber model parallel to the central axis (AT), the chamber shape may be selected from the group comprising a circle, an ellipse, an oval, and a simple regular polygon, wherein the sides of the polygon may especially be curved. Especially, the cardiac chamber model may have an ovoid shape in a cross-section of the cardiac chamber model parallel to the cental axis (AT). Further, the cardiac chamber model may have a circular shape in a cross-section of the cardiac chamber model perpendicular to the central axis (AT).According to a further aspect, the invention may provide a method for preparing the cardiac model as defined above. The method may comprise providing the holder as defined above and a first molding element. Especially, the holder may be configured to host the first molding element. Further, the first molding element may comprise a first molding material. The first molding element may comprise a first cavity defined by a first cavity wall. Further, the method may comprise providing a cell culture to the first cavity. The cell culture may comprise first cells and a first matrix solution. Especially, the first cells may comprise cardiomyocyte-like cells. Further, the method may comprise providing the insert as defined above and a second molding element. The second molding element may be configured at the tubular element first end. Further, the second molding element may comprise a second molding material. The method may comprise aligning the alignment element (as defined above) with the alignment means (as defined above). Further, the method may comprise at least partially inserting the second molding element into the first cavity. Especially, (after insertion,) for at least 70% of the circumference of the second molding element may apply that the second molding element may be separated from the first cavity wall by a first distance (di) selected from the range of 0.1 -0.9 mm, such as from the range of 0.3-0.7 mm. The method may further comprise crosslinking the first matrix solution to provide a crosslinked cell culture. Additionally, the method may comprise exposing the crosslinked cell culture, the first molding material, and the second molding material to a first temperature (Ti) to provide the cardiac model. In embodiments, Ti > 30 °C, such as Ti > 33 °C. Hence, in specific embodiments, the invention may provide a method for preparing the cardiac model as defined above, wherein the method comprises: (A) providing the holder and a first molding element; wherein the holder is configured to host the first molding element; wherein the first molding element comprises a first molding material; wherein the first molding element comprises a first cavity defined by a first cavity wall; (B) providing a cell culture to the first cavity, wherein the cell culture comprises first cells and a first matrix solution; wherein the first cells comprise cardiomyocytelike cells; (C) providing the insert and a second molding element, wherein the second molding element is configured at the tubular element first end; wherein the second molding element comprises a second molding material; (D) aligning the alignment element with the alignment means, and at least partially inserting the second molding element into the first cavity; wherein for at least 70% of the circumference of the second molding element applies that the second molding element is separated from the first cavity wall by a first distance (di) selected from the range of 0.3-0.7 mm; (E) crosslinking the first matrix solution to provide a crosslinked cell culture; and (F) exposing the crosslinked cell culture, the first molding material, and the secondmolding material to a first temperature (Ti) to provide the cardiac model, wherein Ti > 33 °C. Such a method may be relatively convenient, and may consistently result in a beating cardiac model. Further, such a method may facilitate selecting the size and shape of the cardiac chamber model, as well as the thickness of a wall of the chamber cavity.
[0070] The method may comprise providing the first molding element. The first molding element may comprise the first molding material. In embodiment, the first molding material may comprise one or more of gelatin, alginate, and agarose, such as especially at least gelatin. Further, the first molding element may comprise a first cavity, defined by a first cavity wall. The first cavity wall may especially determine (a shape and size of) an outer surface of the chamber cavity (of the cardiac chamber model). The method may comprise preparing the first molding element. Especially, preparing the first molding element may comprise providing a first fluid molding material and a first molding template. In embodiments, the first fluid molding material may comprise one or more of (liquified) gelatin, (liquified) alginate and (liquified) agarose. Further, the first fluid molding material may have a first material temperature (Tmi) selected from the range of 30-50 °C, such as from the range of 33-45 °C, especially from the range of 35-42 °C. Hence, the method may comprise providing the first fluid molding material at the first material temperature (Tmi). Further, the method may comprise adding the first fluid molding material to the holder (cup). Additionally, the method may comprise (partially) inserting the first molding template into the first fluid molding material. The first molding template may especially determine a shape and size of the first cavity wall. That is, the first molding template may comprise a negative for the first cavity. The method may comprise solidifying the first fluid molding material to provide the first molding material. Solidifying the first fluid molding material may comprise cooling the first fluid molding material to a second temperature (T2). In embodiments, T2 < 25 °C may apply, such as T2 < 15 °C, especially T2 < 5 °C. Additionally or alternatively, T2 > -35 °C may apply, such as T2 > -30 °C, especially T2 > -25 °C. Hence, in specific embodiments, solidifying the first fluid molding material may comprise cooling the first fluid molding material to a second temperature (T2), wherein T2 < 15 °C. Further, the method may comprise removing the first molding template to provide the first molding element (with the first cavity) arranged in the holder. Hence, in specific embodiments, the method may further comprise preparing the first molding element, wherein preparing the first molding element may comprise: (A) providing a first fluid molding material and a first molding template; and (B) adding the first fluid molding material to the holder, inserting the first molding template into the first fluid molding material, solidifying the first fluid molding material to provide the first molding material, and removingthe first molding template to provide the first molding element arranged in the holder. Such a method may facilitate directly providing the first molding element in the holder cup, such that the first cavity may be aligned with the second molding element.
[0071] The first molding template may thus comprise a negative for the first cavity. Further, the first molding template may comprise a first template alignment section. The holder (cup) may be configured to support the first template alignment section. Further, the first template alignment section may comprise one or more first template alignment elements. The one or more first template alignment elements may be the same as the (plurality of) alignment element(s) of the insert. Hence, the one or more first template alignment elements may be configured to interact with the alignment means of the holder (lid).
[0072] The method for preparing the cardiac model may further comprise providing a cell culture to the first cavity. The cell culture may comprise first cells and a first matrix solution. Especially, the first cells may comprise cardiomyocyte-like cells. Yet, the first cells may further comprise the secondary cells as defined above. Especially, the first cells may comprise the cardiomyocyte-like cells and the secondary cells in a ratio selected from the range of 2:1 to 50:1, such as from the range of 4:1 to 34:1, especially from the range of 5:1 to 20:1. Hence, in specific embodiments, the first cells may further comprise secondary cells, wherein the first cells may comprise the cardiomyocyte-like cells and the secondary cells in a ratio selected from the range of 4:1 to 34:1. Such a ratio may facilitate that the first cells may comprise relatively more cardiomyocyte-like cells than secondary cells, such that the cardiac chamber model may better mimic (the function of) a human heart.
[0073] The cell culture may comprise the first cells in a cell concentration (Cc). In embodiments, the cell concentration (Cc) may be selected from the range of > 15*106cells / ml, such as from the range of > 20* 106cells / ml, especially from the range of > 25* 106cells / ml. Additionally or alternatively, the cell concentration (Cc) may be selected from the range of < 45*106cells / ml, such as from the range of < 40* 106cells / ml, especially from the range of < 35*106cells / ml. That is, the cell concentration (Cc) may be selected from the range of 15*106cells / ml to 45* 106cells / ml, such as from the range of 20* 106cells / ml to 40* 106cells / ml, especially from the range of 25*106cells / ml to 35*106cells / ml, or such as from the range of 20* 106cells / ml to 30* 106cells / ml. Hence, in specific embodiments, the cell culture may comprise the first cells in a cell concentration (Cc) selected from the range of 20*106cells / ml to 40* 106cells / ml. Such a concentration may facilitate that the incubation time of the crosslinked cell culture (see below) may be relatively short.The cell culture may further comprise a first matrix solution. The first matrix solution may comprise a crosslinking compound (i.e., a compound capable of crosslinking with itself or with the first cells). Especially, the first matrix solution may comprise one or more of fibrinogen, thrombin, a polymer, and collagen. In embodiments, the polymer may be selected from the group comprising alginate methacrylate, gelatin methacryloyl (GelMA), and polyethylene glycol diacrylate (PEGDA). Further, the first matrix solution may comprise a crosslinking activation agent, such as one or more of a photo initiator, a redox initiator, and a divalent cation. Such a first matrix solution may facilitate crosslinking the first matrix solution, such that the first cells may be embedded into a crosslinked cell culture, thereby providing a shape stable precursor of the cardiac chamber model.
[0074] Hence, the first matrix solution may comprise fibrinogen. Especially, the first matrix solution may comprise fibrinogen in a fibrinogen concentration (Cf). The fibrinogen concentration (Cf) may be selected from the range of > 0.3 mg / ml, such as from the range of > 0.5 mg / ml, especially from the range of > 0.7 mg / ml. Additionally or alternatively, the fibrinogen concentration (Cf) may be selected from the range of < 4.5 mg / ml, such as from the range of < 4 mg / ml, especially from the range of < 3.5 mg / ml. That is, the fibrinogen concentration (Cf) may be selected from the range of 0.3-4.5 mg / ml, such as from the range of 0.5-4 mg / ml, especially from the range of 0.7-3.5 mg / ml. Hence, in specific embodiments, the first matrix solution may comprise fibrinogen in a fibrinogen concentration (Cf) selected from the range of 0.5-4 mg / ml.
[0075] Further, the first matrix solution may comprise thrombin. Especially, the first matrix solution may comprise thrombin in a thrombin concentration (Ct). The thrombin concentration (Ct) may be selected from the range of > 0.2 U / ml, such as from the range of > 0.4 U / ml, especially from the range of > 0.5 U / ml. Additionally or alternatively, the thrombin concentration (Ct) may be selected from the range of < 1.0 U / ml, such as from the range of < 0.8 U / ml, especially from the range of < 0.7 U / ml. That is, the thrombin concentration (Ct) may be selected from the range of 0.2- 1.0 U / ml, such as from the range of 0.4-0.8 U / ml, especially from the range of 0.5-0.7 U / ml. Hence, in specific embodiments, the first matrix solution may comprise thrombin in a thrombin concentration (Ct) selected from the range of 0.4-0.8 U / ml.
[0076] The first matrix solution may further comprise a serine protease inhibitor. The serine protease inhibitor may be selected from the group comprising aprotinin, 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF), phenylmethylsulfonyl fluoride (PMSF), antipain, and leupeptin. Especially, the serine protease inhibitor may comprise aprotinin. The first matrix solution may comprise the serine protease inhibitor in an inhibitorconcentration (Ci). In embodiments, Ci > 1.0 pg / ml may apply, such as Ci > 1.5 pg / ml, especially Ci > 2.0 pg / ml. Additionally or alternatively, Ci < 4.0 pg / ml may apply, such as Ci < 3.5 pg / ml, especially Ci < 3.0 pg / ml. That is, the inhibitor concentration (Ci) may be selected from the range of 1.0-4.0 pg / ml, such as from the range of 1.5-3.5 pg / ml, especially from the range of 2.0-3.0 pg / ml. Hence, in specific embodiments, the first matrix solution may further comprise a serine protease inhibitor in an inhibitor concentration (Ci) selected from the range of 1.5-3.5 pg / ml. Such a serine protease inhibitor may reduce the degradation of fibrin in the cardiac chamber model.
[0077] The first matrix solution may further comprise one or more additional components. Especially, the first matrix solution may comprise one or more of Matrigel, methyl cellulose, xanthan gum, gelatin, TGF-P, ET-1, VEGF, a TGF-P inhibitor (e.g. SB431542), a nitric oxide (NO) synthase inhibitor, DMEM, D(+)-glucose, sodium pyruvate, sodium 3-hydroxybutyrate, L-camitine hydrochloride, creatine monohydrate, taurine, phenol red, chemically defined lipid concentrate, GlutaMAX supplement, a-MTG, ITS-X, ascorbic acid-2P, penicillin-streptomycin, sodium hydrogen carbonate, sodium hydroxide, BSA, T3, long R3 (human) IGF-I, dexamethasone, fibroblast growth factor 2, CuSO4, ZnSO4, sodium selenite, ferric citrate, MnSO4, Na2SiC>3, molybdic acid (ammonium salt), NH4VO3, NiSO4, SnCl2, AlCh, AgNO3, Ba(C2H3O2)2, KBr, CdCl2, CoCl2, CrCl3, NaF, GeO2, KI, RbCl, and ZrOCl2.
[0078] The method for preparing the cardiac model may further comprise providing (the insert and) the second molding element. The second molding element may especially be configured at the tubular element first end. Further, the second molding element may comprise a second molding material. Especially, the second molding material may comprise one or more of gelatine, alginate, and agarose, such as especially at least gelatine. The method may comprise preparing the second molding element. Especially, preparing the second molding element may comprise providing a second molding template, the insert, and a second fluid molding material. The second fluid molding material may especially comprise one or more of (liquified) gelatin, (liquified) alginate, and (liquified) agarose. Further, the second fluid molding material may have a second material temperature (Tm2) selected from the range of SOSO °C, such as from the range of 33-45 °C, especially from the range of 35-42 °C. Hence, the method may comprise providing the second fluid molding material at the second material temperature (Tm2).
[0079] The second molding template may comprise a second molding cavity and an insert cavity. The second molding cavity may determine the shape of an internal wall of thechamber cavity. Hence, especially, the second molding cavity may have an ovoid shape (in a cross-section parallel to the central axis (AT). Further, the second molding cavity and the insert cavity may be fluidically coupled. The method may comprise inserting at least part of the insert (such as at least the part of the tubular element configured extending from the alignment section first face) into the insert cavity. Especially, (after insertion,) the first element first end may be configured at a first end of the second molding cavity. Further, the method may comprise adding (by injection through the tubular element) the second fluid molding material to the second molding cavity. Further, the method may comprise solidifying the second fluid molding material to provide the second molding material. Especially, solidifying the second fluid molding material may comprise cooling the second fluid molding material to a third temperature (T3), wherein T3 < 25 °C may apply, such as T3 < 15 °C, especially T3 < 5 °C. Further, the method may comprise removing the second molding template to provide the second molding element physically coupled with the first element first end. Hence, in specific embodiments, the method may further comprise preparing the second molding element, wherein preparing the second molding element may comprise: (A) providing a second molding template, the insert, and a second fluid molding material; wherein the second molding template may comprise a second molding cavity and an insert cavity, wherein the second molding cavity may have an ovoid shape, and wherein the second molding cavity and the insert cavity may be fluidically coupled; (B) inserting at least part of the insert into the insert cavity, wherein the first element first end may be configured at a first end of the second molding cavity; (C) adding the second fluid molding material to the second molding cavity, and solidifying the second fluid molding material to provide the second molding material; and (D) removing the second molding template to provide the second molding element physically coupled with the first element first end. Such a method may provide a strong physical coupling between the second molding element and the tubular element. Further, such a method may ensure a correct alignment of the second molding element with the insert. Herein, the term “first element first end” may also be indicated as “tubular element first end”.
[0080] The method for preparing the cardiac model may further comprise aligning the alignment element with the alignment means, and at least partially inserting the second molding element into the first cavity (of the first molding element). Especially, the second molding element may be fully arranged in the first cavity (after insertion). Yet, the second molding element may be configured physically separated from the first cavity wall (i.e., the second molding element may not be in physical contact with the first cavity wall). Especially, for at least 60%, such as for at least 70%, especially for at least 80%, of the circumference ofthe second molding element may apply that the second molding element may be separated from the first cavity wall by a first distance (di). The > 60%, such as 70%, especially > 80%, of the circumference of the second molding element configured separated from the first cavity wall may especially comprise the (full) circumference of a part of the second molding element configured furthest away from the tubular element first end (along the central axis (AT)). Additionally, the second molding element may be configured separated from the first cavity wall around a full circumference of the second molding element, wherein the distance between the second molding element and the first cavity wall may be > di for a part of the second molding element configured closest to the tubular element first end (along the central axis (AT)). In embodiments, di > 0.1 mm may apply, such as di > 0.3 mm, especially di > 0.4 mm. Additionally or alternatively, di < 0.9 mm may apply, such as di < 0.7 mm, especially di < 0.6 mm. Hence, the first distance (di) may be selected from the range of 0.1 -0.9 mm, such as from the range of 0.3-0.7 mm, especially from the range of 0.4-0.6 mm. The first distance (di) may be equal around the > 60%, such as 70%, especially > 80%, of the circumference of the second molding element configured separated from the first cavity wall. Alternatively, the first distance (di) may be individually selected (from the range provided above) for each point along the > 60%, such as 70%, especially > 80%, of the circumference of the second molding element configured separated from the first cavity wall. Hence, the second molding element may be configured physically separated from the first cavity wall around a full circumference of the second molding element. Such physical separation may facilitate that the chamber opening may be the only opening in the cardiac chamber model.
[0081] The method for preparing the cardiac model may further comprise crosslinking the first matrix solution to provide the crosslinked cell culture. Crosslinking the first matrix solution may comprise crosslinking the fibrinogen with the thrombin. Alternatively, crosslinking the first matrix solution may comprise exposing the collagen to ultraviolet (UV), such as especially UV-A, radiation. Yet, crosslinking the first matrix solution may comprise crosslinking the polymer by Exposing the polymer to UV radiation (wherein the first matrix solution may optionally comprise a photo-initiator such as Irgacure 2959 and / or a redox initiator). The crosslinked cell culture may especially comprise the crosslinked first matrix solution, wherein the first cells may be configured suspended in the crosslinked first matrix solution (and wherein the crosslinked first matrix solution is configured to support the first cells).
[0082] Further, the method for preparing the cardiac model may comprise exposing the crosslinked cell culture, the first molding material, and the second molding material to a firsttemperature (Ti) to provide the cardiac model. Such exposure may liquify the first and second molding material, and may facilitate cell survival and / or cell viability in the crosslinked cell culture. In embodiments, Ti > 30 °C may apply, such as Ti > 33 °C, especially Ti > 35 °C. Additionally or alternatively, Ti < 43 °C may apply, such as Ti < 39 °C, especially Ti < 38 °C. Hence, the first temperature (Ti) may be selected from the range of 30-43 °C, such as from the range of 33-39 °C, especially from the range of 35-38 °C. In embodiments, the first molding material and the second molding material may be configured to liquify at the first temperature Ti. Especially, at the first temperature (Ti), the first molding material may be converted (back) into the first fluid molding material, and the second molding material may be converted (back) into the second fluid molding material.
[0083] In embodiments, the first fluid molding material may provide the (first) fluid of the cardiac model. Further, the second fluid molding material may provide the (second) fluid of the cardiac model. Alternatively, the method may comprise replacing the (liquified) first molding material and the (liquified) second molding material with the fluid (of the cardiac model). Especially, the method may comprise exposing the crosslinked cell culture, the first molding material, and the second molding material to the first temperature (Ti) for a first time period, replacing the (liquified) first molding material and the (liquified) second molding material with the fluid (of the cardiac model), and continuing exposing the crosslinked cell culture (and the fluid) to the first temperature (Ti) for a second time period. In embodiments, the (liquified) first and second molding material may be replaced by the fluid at the first temperature (Ti). Alternatively, replacing the first and second molding material may comprise removing the crosslinked cell culture, first molding material, and second molding material from (an environment having) the first temperature (Ti), wherein replacing the first and second molding material may further comprise re-exposing the crosslinked cell culture (and the fluid) to the first temperature (Ti) for the second time period. Hence, in specific embodiments, the first molding material and the second molding material may be configured to liquify at the first temperature (Ti); wherein the method may further comprise replacing the first molding material and the second molding material with a fluid, and continuing exposing the crosslinked cell culture to the first temperature (Ti) to provide the cardiac model. Replacing the first and second molding materials with the fluid may improve the growing conditions of the first cells.
[0084] Hence, the method may comprise exposing the crosslinked cell culture to the first temperature (Ti). Especially, the method may comprise exposing the crosslinked cell culture to the first temperature (Ti) for (a total time of) at least 2 days, such as at least 3 days, especially at least 4 days, like at least 6 days. Additionally or alternatively, the method maycomprise exposing the crosslinked cell culture to the first temperature (Ti) for (a total time of) at most 100 days, such as at most 80 days, especially at most 60 days, like at most 30 days. Hence, in specific embodiments, the method may comprise exposing the crosslinked cell culture to the first temperature (Ti) for at least 3 days. Such an exposure duration may facilitate that, after the at least 3 days, a cardiac chamber model mimicking an animal or human heart (chamber) may be obtained. Especially, after such an exposure duration, spontaneous pumping activity of the cardiac chamber model may be observed (see also below).
[0085] The method for preparing the cardiac model may further comprise preparing the holder, such as the holder cup. In such embodiments, the holder cup may especially comprise the one or more electrodes and the one or more electrical tracks. Preparing the holder (cup) may comprise providing an electrically insulating material as described above (e.g. polyimide). Further, preparing the holder (cup) may comprise depositing electrically conductive material onto the electrically insulating material (wherein the electrically conductive material may be as described above). For instance, the method for preparing the cardiac model may comprise depositing (a composition comprising) silver onto the electrically insulating material for the one or more electrical tracks, and depositing a carbon-comprising material onto the electrically insulating material for the one or more electrodes. Preparing the holder (cup) may comprise preparing the one or more electrodes (and one or more electrical tracks) using doctor blade coating, lithography, additive manufacturing (e.g. 3D-printing), and / or (chemical or physical) vapor deposition.
[0086] Hence, preparing the holder (cup) may comprise providing the one or more electrodes (and electrical tracks) using (chemical or physical) vapor deposition (and / )or doctor blade coating. As such, preparing the holder (cup) may comprise applying a barrier layer (e.g. a photomask) on the electrically insulating material, wherein the barrier layer comprises one or more through holes (and wherein the electrically insulating material is exposed through the one or more through holes). Further, preparing the holder (cup) may comprise depositing the electrically conductive material onto the barrier layer using chemical or physical vapor deposition. Alternatively, preparing the holder (cup) may comprise depositing the electrically conductive material onto at least part of the barrier layer, and (distributing and) removing excess electrically conductive material using a doctor blade. Further, preparing the holder (cup) may comprise removing the barrier layer to provide the electrically insulating material with the one or more electrodes (and electrical tracks) provided thereon. Optionally, the steps of applying a barrier layer, depositing electrically conductive material, and removing the banner layer may be repeated several times, wherein each bamer layer may have different and / ordifferently-located though holes. As such, the method may facilitate using different electrically conductive materials for the one or more electrodes and the one or more electrical tracks.
[0087] Alternatively, preparing the holder (cup) may comprise depositing the electrically conductive material using additive manufacturing. For instance, the electrically conductive material may be deposited using a 3D-printer. Especially, the electrically conductive material may be deposited according to a predetermined pattern. In embodiments, preparing the holder (cup) using additive manufacturing may comprise depositing different electrically conductive materials (according to different patterns) for the one or more electrodes and the one or more electrical tracks. Hence, in specific embodiments, the method for preparing the cardiac model may further comprise preparing the holder, wherein the holder comprises a holder cup, wherein the holder cup comprises one or more electrodes, and wherein preparing the holder comprises (i) providing an electrically insulating material, and (ii) depositing electrically conductive material onto the electrically insulating material (using one or more of doctor blade coating, additive manufacturing, chemical vapor deposition, and physical vapor deposition). Preparing the holder (cup) by depositing of the electrically conductive material on the electrically insulating material may provide the benefit that the size, layout, and / or material of the one or more electrodes may be relatively easily adjusted, and / or relatively easily customized to suit different applications.
[0088] The deposited electrically conductive material may (already) provide the one or more electrodes (and electrical tracks). Alternatively, preparing the holder (cup) may comprise curing the electrically conductive material, e.g. at an elevated temperature selected from the range of 60-200 °C, to provide the holder cup comprising (the one or more electrical tracks and) the one or more electrodes. Hence, in specific embodiments, the method for preparing the cardiac model may further comprise preparing the holder, wherein the holder comprises a holder cup, wherein the holder cup comprises one or more electrodes, and wherein preparing the holder comprises (i) providing an electrically insulating material, (ii) depositing electrically conductive material onto the electrically insulating material, and (iii) curing the electrically conductive material to provide the holder cup comprising the one or more electrodes.
[0089] As indicated above, especially the cup base may comprise the one or more electrodes (and the one or more electrical tracks). As such, preparing the holder may especially comprise (i) providing an electrically insulating material, (ii) depositing electrically conductive material onto the electrically insulating material, (iii) curing the electrically conductive material to provide the cup base comprising the one or more electrodes, and (iv) combining the cup base with the cup wall to provide the holder cup.According to a further aspect, the invention may provide a system for preparing a cardiac model (such as especially the cardiac model defined above). The system may comprise a module. Especially, the module may comprise a holder (such as the holder defined above) configured to host a first molding element (as defined above), an insert (as defined above), and a second molding element (as defined above). The holder may comprise an alignment means (as also defined above). Further, the first molding element may comprise a first molding material (as defined above). The first molding element may comprises a first cavity defined by a first cavity wall (as defined above). Further, the insert may comprise an alignment section and a tubular element (as defined above). Especially, the alignment section may comprise an alignment element (as defined above). The alignment element may be configured to interact with the alignment means. Further, the tubular element may be configured (i) intersecting with the alignment section, and (ii) (partially) extending from the alignment section at an alignment section first face (see also above). The tubular element may have a first internal (equivalent circular) diameter (Di) at a tubular element first end (as defined above). In embodiments, as indicated above, 0.7 mm < Di < 2.3 mm, such as 1.0 mm < Di < 2.0 mm. Further, the tubular element first end may comprise one or more first end protrusions (as defined above). Additionally, the tubular element may have a second internal (equivalent circular) diameter (D2) at a tubular element second end opposite the tubular element first end (see also above). In embodiments, 2.3 mm < D2 < 3.7 mm, such as 2.5 mm < D2 < 3.5 mm. The second molding element may be configured at the tubular element first end. Further, the second molding element may comprise a second molding material (see also above). The second molding element may (during use of the system) be configured to at least partially extend into the first cavity (as indicated above). Especially, for at least 60%, such as at least 70%, of the circumference of the second molding element may apply that the second molding element may be separated from the first cavity wall by a first distance (di) selected from the range of 0.1-0.9 mm, such as from the range of 0.3-0.7 mm (see also above). Hence, in specific embodiments, the invention may provide a system for preparing a cardiac model, wherein the system comprises a module, wherein the module comprises a holder configured to host a first molding element, an insert, and a second molding element; wherein the holder comprises an alignment means; wherein the first molding element comprises a first molding material; wherein the first molding element comprises a first cavity defined by a first cavity wall; wherein the insert comprises an alignment section and a tubular element, wherein: (A) the alignment section comprises an alignment element, wherein the alignment element is configured to interact with the alignment means, wherein the tubular element is configured (i)intersecting with the alignment section, and (ii) extending from the alignment section at an alignment section first face; (B) the tubular element has a first internal diameter (Di) at a tubular element first end, wherein 1.0 mm < Di < 2.0 mm; wherein the tubular element first end comprises one or more first end protrusions; wherein the tubular element has a second internal diameter (D2) at a tubular element second end opposite the tubular element first end, (wherein 2.5 mm < D2 < 3.5 mm;) and (C) the second molding element is configured at the tubular element first end; wherein the second molding element comprises a second molding material; wherein the second molding element is configured to at least partially extend into the first cavity, and wherein for at least 70% of the circumference of the second molding element applies that the second molding element is separated from the first cavity wall by a first distance (di) selected from the range of 0.3-0.7 mm. Such a system may facilitate providing cardiac chamber models in a reproducible and simple manner. Further, such a system may especially be modular, such that different shapes and sizes of cardiac chamber models may be provided (by adjusting the first and second molding elements).
[0090] As also indicated above, the second molding element may have an ovoid shape in a cross-section of the second molding element parallel to the central axis (AT). Further, especially during use of the system, the second molding element may be configured fully arranged in the first cavity (wherein the second molding element may be configured physically separated from the first cavity wall by at least the first distance (di)). Hence, in specific embodiments, the second molding element may have an ovoid shape, wherein the second molding element may be configured fully arranged in the first cavity.
[0091] Further, as also indicated above in relation to the measurement system, the system may comprise a plurality of modules (each comprising the holder, the insert, the first molding element, and the second molding element) arranged in the first array as defined above. Especially, the plurality of modules may be configured mechanically coupled in the first array. Hence, in specific embodiments, the system may comprise a plurality of modules arranged in a first array, wherein the plurality of modules may be configured mechanically coupled in the first array.
[0092] According to a further aspect, the invention may provide a use of the measurement system as defined above for one or more of disease modelling, drug testing, drug screening, and targeted therapeutics. Additionally or alternatively, the invention may provide a use of the cardiac model as defined above for one or more of disease modelling, ding testing, drag screening, and targeted therapeutics. Especially, a drag or therapeutic may be added to the cardiac chamber model, wherein the response of the cardiac chamber model to the drag ortherapeutic may be determined and / or monitored. Additionally or alternatively, the cardiac chamber model may be configured to mimic a diseased heart (chamber) of an animal or human, wherein the progression of the disease and / or the effect of the disease on a cardiac functional parameter may be determined using the measurement system and / or the cardiac model. Hence, in specific embodiments, the invention may provide a use of the measurement system as defined above or the cardiac model as defined above for one or more of disease modelling, drag testing, drag screening, and targeted therapeutics. Such a use may facilitate that the measurement system and / or cardiac model may replace animal testing, thereby providing a more humane method for testing drags or therapeutics, and / or providing a more humane method to study (cardiac) diseases.
[0093] The embodiments described herein are not limited to a single aspect of the invention. For example, an embodiment describing the method may, for example, further relate to the system, especially to an operational mode of the system, or especially to the control system. Similarly, an embodiment of the system describing an operation of the system may further relate to embodiments of the method. In particular, an embodiment of the method describing an operation (of the system) may indicate that the system may, in embodiments, be configured for and / or be suitable for the operation.
[0094] A system may execute an action in a “mode” or “operational mode”. Likewise, in a method, an action, stage, or step may be executed in a “mode” or “operational mode”. This does not exclude that the system may also be adapted for providing one or more other operational modes. Likewise, this may not exclude that before and / or after executing the mode one or more other modes may be executed. The term “operational mode” especially refers to a way in which a system operates. The control system may be configured to provide at least the operational mode. Would other modes be available, the choice of such modes may especially be executed via a user interface, though other options, like executing a mode in dependence of a sensor signal or a (time) scheme, may also be possible. Hence, the control system may control in dependence of one or more of an input signal of a user interface, a sensor signal (of a sensor), and a timer. The term “timer” may refer to a clock and / or a predetermined time scheme.
[0095] BRIEF DESCRIPTION OF THE DRAWINGS
[0096] Embodiments of the invention will now be described, by way of example only, with reference to the accompanying schematic drawings in which corresponding reference symbols indicate corresponding parts, and in which: Fig. 1 schematically depicts an embodiment of the measurement system; Figs. 2-3 schematically depict embodiments of thesystem; Fig. 4 schematically depicts an embodiment of the cardiac model; Fig. 5 schematically depicts an embodiment of the method for preparing the cardiac model; Fig. 6 schematically depicts experimental observations obtained using embodiments of the measurement system and the cardiac model; and Fig. 7 schematically depicts the holder cup comprising one or more electrodes. The schematic drawings are not necessarily to scale.
[0097] DETAILED DESCRIPTION OF THE EMBODIMENTS
[0098] Fig. 1 schematically depicts an embodiment of the measurement system 7000 for measuring a cardiac functional parameter of a cardiac chamber model 600. The measurement system 7000 may comprise a distance sensor 710, a module 200, and a control system 720. On the right of Fig. 1, a zoom-in of a cross-sectional view of the module 200 (without the module lid 205) is depicted. The module 200 may comprise a holder 300 and an insert 400. Especially, the holder 300 may be configured to host the cardiac chamber model 600 and at least part of the insert 400. Further, the holder 300 may comprise an alignment means 310. The insert 400 may comprise an alignment section 410 and a tubular element 420. The alignment section 410 may comprise an alignment element 415. Especially, the alignment element 415 may be configured to interact with the alignment means 310. Further, the tubular element 420 may be configured (i) intersecting with the alignment section 410, and (ii) (partially) extending from the alignment section 410 at an alignment section first face 411. The tubular element 420 may have a first internal (equivalent circular) diameter Di at a tubular element first end 421. In embodiments, 1.0 mm < Di < 2.0 mm may apply. Further, the tubular element first end 421 may be configured to extend into the holder 300 (during use of the measurement system 7000). Additionally, the tubular element first end 421 may comprise one or more first end protrusions 425. The one or more first end protrusions 425 may be configured to support the cardiac chamber model 600. Further, the tubular element 420 may have a second internal (equivalent circular) diameter D2 at a tubular element second end 422 opposite the tubular element first end 421. In embodiments, 2.5 mm < D2 < 3.5 mm may apply. Further, the tubular element 420 may have a central axis AT perpendicular to the second internal diameter D2 (and the first internal diameter Di). The distance sensor 710 may be configured to emit a sensor signal along a first axis Ai configured at a first angle oil with the central axis AT. In embodiments, oil < 20° may apply. Further, the distance sensor 710 may be configured to determine a distance to a fluid (level) in the tubular element 420. The distance sensor 710 may be configured to (subsequently) provide a distance signal to the control system 720. Especially,the control system 720 may be configured to determine the cardiac functional parameter based on the distance signal (and the sensor signal).
[0099] The distance sensor 710 may especially comprise an optical sensor (e.g. a confocal sensor). Hence, the sensor signal may in embodiments comprise an optical signal. Further, the measurement system 7000 may comprise a second sensor 740 (e.g. a camera). The second sensor 740 may be configured to determine one or more of: (i) a first (largest) area Aci of the cardiac chamber model 600 in a first cross-section of the cardiac chamber model 600 parallel to the central axis AT, and (ii) a second (largest) area Ac2 of the cardiac chamber model 600 in a second cross-section of the cardiac chamber model 600 perpendicular to the central axis AT. Further, the second sensor 740 may be configured to provide a related second sensor signal to the control system 720. The control system 720 may be configured to determine the cardiac functional parameter based on the distance signal and the second sensor signal. As indicated in Fig. 1, the second sensor 740 may comprise a primary second sensor 741 and a secondary second sensor 742. Especially, the primary second sensor 741 may be configured to determine the first (largest) area Am, and the secondary second sensor 742 may be configured to determine the second (largest) area Ac2- Turning back to the module 200, the one or more first end protrusions 425 (of the insert 400) may comprise a protruding disc 426. The protruding disc 426 may be configured protruding from the tubular element first end 421 (in a direction orthogonal to the central axis AT) by a protrusion width Wp. In embodiments, the protrusion width Wpmay be selected from the range of 0.05-0.5 mm.
[0100] Further, the alignment section 410 may comprise an alignment section second face 412 opposite the alignment section first face 411. Especially, the tubular element second end 422 may be configured at a side of the alignment section second face 412. Further, the tubular element 420 may comprise a tubular element top section 428. The tubular element top section 428 may have a second length L2 (perpendicular to the second internal diameter D2 and parallel to the center axis AT). In embodiments, L2 > 4 mm. Further, the second internal diameter D2 may deviate < 10% over the second length L2. As indicated in Fig. 1, the tubular element 420 may further be configured extending from the alignment section 410 at the alignment section second face 412 opposite the alignment section first face 411. Especially, the tubular element 420 may extend from the alignment section second face 412 with the tubular element top section 428.
[0101] The tubular element 420 may further comprise a tubular element middle section 427. The tubular element middle section 427 may be configured intersecting the alignmentsection 410. Further, in embodiments where the tubular element 420 may extend from the alignment section second face 412, the tubular element middle section 427 may be configured between the alignment section first face 411 and the alignment section second face 412. The tubular element middle section 427 may have a third internal (equivalent circular) diameter D3 at the alignment section first face 411. Further, the tubular element middle section 427 may have a fourth internal (equivalent circular) diameter D4 at a middle section second end 4272 opposite the alignment section first face 411 (and optionally at the alignment section second face 412). In embodiments, 0.95*Di < D3 < 1.05*Di may apply. Additionally or alternatively, 0.95 *D2 < D4 < 1.05*D2 may apply. Further, an internal diameter of the tubular element middle section 427 may taper from D4 to D3 along the tubular element middle section 427.
[0102] The holder 300 may comprise a holder cup 320 and a holder lid 330. The holder cup 320 may be configured to host the cardiac chamber model 600. Further, the holder lid 330 may comprise the alignment means 310 and a holder central opening 340. The insert 400 may be configured at least partially extending (into the holder cup 320) through the holder central opening 340. The holder lid 330 may comprise a lid opening 331. Further, the alignment means 310 may comprise an alignment protrusion 311 (see Fig. 2). The alignment protrusion 311 may be configured between the lid opening 331 and the holder central opening 340.
[0103] The module 200 may further comprise a module lid 205. The module lid 205 may be configured to at least partially cover the holder cup 320 and the holder lid 330. Further, the module lid 205 may comprise a first module lid opening 2051. Especially, the tubular element 420 (and optionally part of the alignment section 410) may be configured partially extending through the first module lid opening 2051. Further, the module lid 205 may comprise a second module lid opening 2052 (as depicted for the modules 200 at the bottom left of the first array 210). Along a direction of the central axis AT, the second module lid opening 2052 may be configured aligned with the lid opening 331.
[0104] The measurement system 7000 may comprise a plurality of modules 200 arranged in a first array 210. In such embodiments, the measurement system 7000 may further comprise a movement element 730. The movement element 730 may be configured to control a position of the distance sensor 710 relative to the plurality of modules 200. Further, the control system 720 may be configured to control the movement element 730. The movement element 730 may be configured to control a position of the distance sensor 710. In such embodiments, the movement element 730 may comprise a holder configured to host the distance sensor 710. Additionally or alternatively, the movement element 730 may beconfigured to control a position of the first array 210. In such embodiments, the movement element 730 may comprise a platform configured to host and / or support the first array 210.
[0105] Fig. 1 may further schematically depict an embodiment of the measurement method for measuring a cardiac functional parameter of a cardiac chamber model 600. The measurement method may especially comprise providing a cardiac model 50. The cardiac model 50 may comprise the cardiac chamber model 600 supported by the tubular element 420 (as defined above). Especially, the one or more first end protrusions 425 (of the tubular element 420) may be configured to support the cardiac chamber model 600. The measurement method may further comprise providing a sensor signal to the cardiac model 50 along a first axis Ai. Further, the measurement method may comprise determining a distance to a fluid (level) in the tubular element 420, and providing a (related) distance signal to a control system 720. In embodiments, the measurement method may comprise deteimining a change in fluid level over time in the tubular element 420 based on the distance signal (and the sensor signal). In such embodiments, the measurement method may comprise determining the cardiac functional parameter based on the distance signal, especially based on the change in fluid level over time.
[0106] The measurement method may comprise providing a drug or therapeutic to the cardiac chamber model 600 (through the lid opening 331, and optionally through the second module lid opening 2052). Additionally or alternatively, the measurement method may comprise providing a(n external) stimulus to the cardiac chamber model 600. Additionally or alternatively, the measurement method may comprise mimicking a (cardiac) disease with the cardiac chamber model 600. In such embodiments, the measurement method may further comprise determining a first cardiac functional parameter at a first time ti (before addition of the drug, therapeutic, or stimulus), and determining a second cardiac functional parameter at a second time t2 (after addition of the drug, therapeutic, or stimulus). Further, the measurement method may comprise comparing the first cardiac functional parameter with the second cardiac functional parameter.
[0107] Fig. 1 further schematically depicts an embodiment of the cardiac model 50 comprising the module 200. Here, the module 200 may further comprise a fluid 540 and the cardiac chamber model 600. Especially, the holder 300 may be configured to host (at least part of) the fluid 540. Further, the cardiac chamber model 600 may be configured at the tubular element first end 421. As indicated above, the one or more first end protrusions 425 may be configured to at least partially support the cardiac chamber model 600. Further, the cardiac chamber model 600 may be configured at least partially submerged in the fluid 540. The cardiac chamber model 600 may comprise first cells 52 (suspended in a crosslinked cell culture530). The first cells 52 may comprise cardiomyocyte-like cells 521 (and optionally secondary cells 522). Further, the cardiac chamber model 600 may comprise a chamber cavity 610 and a chamber opening 620. The chamber cavity 610 may be configured to host (part of) the fluid 540. Further, the chamber cavity 610 may be configured fluidically coupled with the tubular element 420 via the chamber opening 620. The cardiac chamber model 600 may have an ovoid shape (in a cross-section parallel to the central axis AT). Further, the cardiac chamber model 600 may be configured to contract, thereby altering a fluid level in the tubular element 420.
[0108] The fluid 540 hosted by the holder 300 and the chamber cavity 610 may be the same fluid 540. Alternatively, the fluid 540 may comprise a first fluid 541 and a second fluid 542. Especially, the holder 300 may be configured to host the first fluid 541, and the chamber cavity 610 may be configured to host the second fluid 542. The first fluid 541 and the second fluid 542 may differ in one or more of a viscosity, a color, a composition, and a concentration of at least one component.
[0109] Fig. 2 schematically depicts an embodiment of the system 1000 for preparing a cardiac model 50. The system 1000 may comprise a module 200 (such as the module 200 as defined above). The module 200 may comprise the holder 300 configured to host a first molding element 30, the insert 400, and a second molding element 40. Further, the holder 300 may comprise an alignment means 310. The first molding element 30 may comprise a first molding material 31. Further, the first molding element 30 may comprise a first cavity 35 defined by a first cavity wall 36. The insert 400 may comprise an alignment section 410 and a tubular element 420. Further, the alignment section 410 may comprise an alignment element 415. Especially, the alignment element 415 may be configured to interact with the alignment means 310. The tubular element 420 may be configured (i) intersecting with the alignment section 410, and (ii) (partially) extending from the alignment section 410 at an alignment section first face 411. Further, the tubular element 420 may have the first internal (equivalent circular) diameter Di at the tubular element first end 421. In embodiments, 1.0 mm < Di < 2.0 mm (as indicated above). The tubular element first end 421 may comprise one or more first end protrusions 425. Further, the tubular element 420 may have the second internal (equivalent circular) diameter D2 at the tubular element second end 422 opposite the tubular element first end 421. As indicated above, in embodiments 2.5 mm < D2 < 3.5 mm. The second molding element 40 may be configured at the tubular element first end 421. Further, the second molding element 40 may comprise a second molding material 41. Especially, (during use of the system 1000,) the second molding element 40 may be configured to at least partially extend into the first cavity 35. In embodiments, for at least 70% of the circumference of the second moldingelement 40 may apply that the second molding element 40 may be separated from the first cavity wall 36 by a first distance di selected from the range of 0.3-0.7 mm.
[0110] Especially, (during use of the system 1000,) the second molding element 40 may be configured fully arranged in the first cavity 35, as also depicted in Fig. 2. Here, the second molding element 40 may have the first distance di to the first cavity wall 36 at the bottom part of the second molding element 40 (furthest from the tubular element first end 421). At the top part of the second molding element 40 (closest to the tubular element first end 421), the second molding element 40 may be configured separated from the first cavity wall 36 by a distance > di. That is, the second molding element 40 may be configured physically separated from the first cavity wall 36 around the full circumference of the second molding element 40. Further, the second molding element 40 may have an ovoid shape (in a cross-section parallel to the central axis AT).
[0111] As indicated above, the tubular element 420 may be configured extending from the alignment section 410 at the alignment section second face 412. In such embodiments, the tubular element top section 428 (extending from the alignment section second face 412 by the second length L2) may comprise one or more, such as especially a plurality of, (fluid) level marks 430. The (fluid) level marks 430 may be configured around (at least part of) an outer circumference of the tubular element top section 428. Especially, the plurality of (fluid) level marks 430 may be configured evenly distributed along the second length L2.
[0112] Fig. 3 schematically depicts an embodiment of the first array 210. The system 1000 may comprise a plurality of modules 200 arranged in the first array 210 as defined above. The plurality of modules 200 may be configured mechanically coupled in the first array 210. Especially, the holder cups 320 of the plurality of modules 200 may be configured mechanically coupled, wherein each module 200 may have an individually separable holder lid 330 (i.e., the holder lids 330 may not be mechanically coupled). The first array 210, such as especially the holder cups 320, may be configured as a 12-well plate. Fig. 3 further depicts a third molding template 830, which may be used to provide the second molding template 550 (see below).
[0113] Fig. 4 schematically depicts an embodiment of the cardiac chamber model 600 configured supported by the tubular element 420. Here, the insert 400 is configured supported by the holder lid 330 (and aligned with the holder lid 330 via the alignment means 310 and the alignment element 415), wherein the holder lid 330 is separated from the holder cup 320.
[0114] Fig. 5 schematically depicts an embodiment of the method for preparing the cardiac model 50. The method may comprise providing the holder 300 and a first moldingelement 30 (see Fig. 5(IV)). The holder 300 may be configured to host the first molding element 30. The first molding element 30 may comprise a first molding material 31. Further, the first molding element 30 may comprise a first cavity 35 defined by a first cavity wall 36. The method may further comprise providing a cell culture 520 to the first cavity 35. The cell culture 520 may comprise first cells 52 and a first matrix solution 523 (see Fig. 5(111)). Especially, the first cells 52 may comprise cardiomyocyte-like cells 521 (and optionally secondary cells 522). Further, the method may comprise providing the insert 400 and a second molding element 40. The second molding element 40 may be configured at the tubular element first end 421. Further, the second molding element 40 may comprise a second molding material 41. The method may comprise aligning the alignment element 415 with the alignment means 310, and at least partially inserting the second molding element 40 into the first cavity 35. Especially, (after insertion,) for at least 70% of the circumference of the second molding element 40 may apply that the second molding element 40 may be separated from the first cavity wall 36 by the first distance di selected from the range of 0.3-0.7 mm. The method may comprise crosslinking the first matrix solution 523 to provide a crosslinked cell culture 530. Further, the method may comprise exposing the crosslinked cell culture 530, the first molding material 31, and the second molding material 41 to a first temperature Ti to provide the cardiac model 50 (such as especially the cardiac chamber model 600 configured supported by the tubular element 420). In embodiments, Ti > 33 °C may apply.
[0115] The first molding material 31 and the second molding material 41 may be configured to liquify at the first temperature Ti. As such, the method may further comprise replacing the (liquified) first molding material 31 and the (liquified) second molding material 41 with the fluid 540 (or optionally with the first fluid 541 and the second fluid 542). Further, the method may comprise continuing exposing the crosslinked cell culture 530 to the first temperature Ti (in the presence of the fluid 540) to provide the cardiac model 50. In total, the method may comprise exposing the crosslinked cell culture 530 to the first temperature Ti for at least 3 days (before using the cardiac model 50 in e.g. the measurement system 7000).
[0116] The method may further comprise preparing the first molding element 30, as depicted in Fig. 5(1). Preparing the first molding element 30 may comprise providing a first fluid molding material 3 and the first molding template 510. Further, preparing the first molding element 30 may comprise adding the first fluid molding material 3 to the holder 300, inserting the first molding template 510 into the first fluid molding material 3, solidifying the first fluid molding material 3 to provide the first molding material 31 , and removing the first molding template 510 to provide the first molding element 30 (with the first cavity 35) arrangedin the holder 300. Solidifying the first fluid molding material 3 may comprise cooling the first fluid molding material 3 to a second temperature T2. In embodiments, T2 < 15 °C may apply.
[0117] Further, the method may comprise preparing the second molding element 40 (as schematically depicted in Fig. 5(H)). Preparing the second molding element 40 may comprise providing a second molding template 550, the insert 400, and a second fluid molding material 4. As shown in Fig. 5(11), the second molding template 550 may comprise two halves, which for clarity and illustrative purposes are depicted physically separated. The second molding template 550 may comprise a second molding cavity 551 and an insert cavity 552. Especially, the second molding cavity 551 may have an ovoid shape. Further, the second molding cavity 551 and the insert cavity 552 may be fluidically coupled. Preparing the second molding element 40 may further comprise inserting at least part of the insert 400 into the insert cavity 552, wherein the first element first end 421 (or “tubular element first end 421”) may be configured at a first end of the second molding cavity 551. Further, preparing the second molding element 40 may comprise adding (by injection) the second fluid molding material 4 to the second molding cavity 551, and solidifying the second fluid molding material 4 to provide the second molding material 41. Further yet, preparing the second molding element 40 may comprise removing the second molding template 550 to provide the second molding element 40 physically coupled with the first element first end 421.
[0118] The second molding template 550 may be prepared using a third molding template 830 (shown in Fig. 5(1)). The third molding template 830 may be arranged suspended in a (rectangular) container, wherein the container may be filled with a (fluid) third molding material (e.g. PDMS) which, after hardening, removal of the third molding template 830, and removal from the container, may provide the second molding template 550. Especially, the third molding template 830 may comprise (such as be) a negative of the second molding cavity 551 and the insert cavity 552.
[0119] Experiments
[0120] Preparation of the cardiac model 50
[0121] An embodiments of the method for preparing a cardiac model 50 is briefly described herein for illustrative purposes. It will be clear to the person skilled in the art that the method is not limited to the specific steps, components, and conditions described below.
[0122] For preparing the cardiac model 50, liquified gelatin (Sigma- Aldrich G1890; 10%) was prepared with an in-house developed cardiomyocyte culture medium (described as the cardiomyocyte medium in Cofino-Fabres, C. etal. (2024); Micro-Engineered Heart Tissues On-Chip with Heterotypic Cell Composition Display Self-Organization and Improved CardiacFunction, Adv. Healthcare Mater., 13, 2303664). The liquified gelatin serves as the first fluid molding material 3, and 4.5 mL of liquified gelatin was added to each holder cup 320 of a first array 210 of modules 200, followed by placement of a holder lid 330 with the first molding template 510. The gelatin was then solidified via cooling at -20 °C (T2), establishing a U-shaped first cavity 35 upon removal of the first molding template 510. In parallel, the second molding element 40 was created via injection molding by assembling two PDMS halves with a negative mold design (i.e., the second molding template 550). The insert 400 was positioned on the top, and liquified gelatin (as the second fluid molding material 4) was injected to fill the mold. After solidification, the PDMS halves were removed, leaving the second molding element 40 anchored to the tubular element 420.
[0123] Next, human induced pluripotent stem cell-derived cardiomyocytes 521 differentiated from human induced pluripotent stem cell line WTC-11 (WT GM25256*G0002) and human cardiac fibroblasts (PromoCell) (as secondary cells 522) were resuspended at a 10: 1 ratio. An extracellular first matrix solution 523 consisting of fibrinogen (final concentration of 2 mg / mL, Sigma-Aldrich F8630), Matrigel (final concentration of 1 mg / mL), and aprotinin (final concentration of 2.5 pg / mL, Sigma-Aldrich, Al 153) was prepared on ice and added to the cell suspension to yield a final concentration of first cells 52 of 25 million cells / mL. Next, 0.6 U / mL of thrombin (Sigma, T7513) was added to the solution. 150 pL of the resulting cell culture 520 was quickly loaded into the first molding element 30, followed by the placement of the holder lid 330 with the insert 400 anchored to the second molding element 40. The module 200 was incubated at room temperature for 10 min to ensure fibrinogen polymerization of the cell suspension within the cavity between the two gelatin molds (thereby providing the crosslinked cell culture 530). Next, the module 200 was incubated at 37 °C to induce thermal degradation of the gelatin (i.e., of the first and second molding material 31,41). This resulted into a hollow cardiac chamber cavity 610 internally and externally surrounded by liquified gelatin, and attached to the tubular element 420. Partial medium changes (with 2 mL in-house cardiomyocyte medium as the fluid 540) were conducted every day for a week followed by complete daily medium changes (4.5 mL) thereafter. After an average of 6 days in culture, the cardiac chamber models 600 started displaying spontaneous beating activity synchronized with a bidirectional flow observed inside the tubular element 420, demonstrating the fluid pumping capability of the cardiac chamber models 600. Unless specified otherwise, the volume of fluid 540 in the chamber cavity 610 and tubular element 420 was 50 pl.
[0124] Measuring cardiac functional parameters using the measurement system 7000For the measurements, a confocal distance sensor 710 consisting of a confocal chromatic controller (Microepsilon, IFC2411) and an optical displacement sensor (Microepsilon, IFS2403-10) was aligned at the top of the tubular element 420, allowing for the non-invasive detection of liquid displacement during beating cycles. The distance sensor 710 was mounted on a Nikon Ti2 Eclipse microscope (Nikon instruments). The position of the modules 200 in the first array 210 could be precisely controlled via a motorized stage of the microscope (i.e., the movement element 730) to align (the first axis Ai of) the distance sensor 710 with (the central axis AT of) the tubular element 420.
[0125] In a first proof-of-concept study, the cardiac chambers models 600 were subjected to electric field stimulation (10 ms biphasic pulses, 4-5 V / cm, 1-3 Hz), and a change in beating frequency of the cardiac chamber models 600 as a function of a change in frequency of the electric field was recorded. The results are shown in the table below.
[0126] Frequency of stimulation Beating frequency Stroke volume Cardiac output (Hz) (Hz) (pL) (pL / min) - (spontaneous beating) 0.8 8.2 399
[0127] 1 1.0 8.8 521
[0128] 1.5 1.5 7.8 704
[0129] 2 2.0 6.3 751
[0130] 2.5 2.5 4.2 623
[0131] 3 1.5 6.05 534
[0132]
[0133] As can be seen from the table above, the cardiac chamber models 600 were able to follow the pacing frequency of the electric field up to 2.5 Hz. In Fig. 6A, the normalized (degree of) contraction C (in arbitrary units) of the cardiac chamber model 600 over time T (in seconds) is schematically depicted for electrical stimulation with 1 Hz (Fig. 6A(1)) and 2 Hz (Fig. 6A(11)). Here, the dashed line indicated by S indicates the time point at which the electrical stimulation was started. Further, the filled triangles indicate the point of maximum contraction C, while the filled circles indicate the point of maximum relaxation during each pumping action. The (degree of) contraction C may especially be related to the distance signal, wherein a smaller distance to the fluid (level) indicates a larger (degree of) contraction (as the fluid may be pushed upwards along the tubular element 420 during contraction). Electrical pacing of engineered cardiac tissues may be especially relevant for observing tissue responses at fixed beating frequencies, ensuring consistency and comparability across studies. However, such electrical pacing may often be incompatible with pressure-volume catheters that may be used in prior art for the characterization of cardiac chamber pump performance. Hence, the(non-invasive) measurement system 7000 may provide electrical pacing of a cardiac chamber model 600, thereby improving consistency and comparability across studies.
[0134] In a second proof-of-concept study, the response of the cardiac chamber models 600 to drug compounds was evaluated. Upon administration of fl-adrenergic agonist isoproterenol (10 pM), an increase in beating frequency and stroke volume was observed. Further, administration of calcium channel blocker nifedipine (10 pM) resulted in complete attenuation of the beating. The results are shown in the table below. Please note that the baseline measurement (i.e. the cardiac chamber model 600 without any stimulus) differs in cardiac functional parameters compared to the baseline measurement in the first proof-of-concept study. This discrepancy may be due to the age of the cardiac chamber model 600 at the time of the measurement, as the cardiac functional parameters of the cardiac chamber model 600 may change over time.
[0135] Stimulus Beating frequency Stroke volume Cardiac output (Hz) (pL) (pL / min) None (baseline) 0.5 3.0 85 Isoproterenol 1.3 3.3 269
[0136] Nifedipine 0.0 0.0 0
[0137]
[0138] The results of the second proof-of-concept study are further schematically depicted in Fig. 6B, where Fig. 6B(I) indicates the (degree of) contraction C of the cardiac chamber model 600 over time T (in seconds) for the baseline measurement, and where Fig.
[0139] 6B(II) indicates the (degree of) contraction C of the cardiac chamber model 600 over time T after addition of isoproterenol. The physiological responses of the cardiac chamber model 600 to isoproterenol and nifedipine are in line with the expected physiological response from a (human) heart. Hence, the measurement system 7000 and the cardiac model 50 may provide a suitable platform for standardized drug response evaluation in terms of volumetric readouts.
[0140] In a third proof-of-concept study, the cardiac chamber models 600 were subjected to increasing volumetric loads via the tubular element 420. To this end, 50-80 pL of a liquid was added to the cardiac chamber model 600 and tubular element 420, and the beating frequency, stroke volume, cardiac output, and ratio of stroke volume (SV) to area were measured. The results are shown in the table below.
[0141] Volumetric load Beating Stroke volume Cardiac output Ratio SV / area (pL) frequency (Hz) (pL) (pL / min)
[0142] 50 0.5 3.7 106 0.28
[0143]
[0144] Volumetric load Beating Stroke volume Cardiac output Ratio SV / area (pL) frequency (Hz) (pL) (pL / min)
[0145] 60 0.6 3.7 127 0.26
[0146] 70 0.6 4.21 158 0.30
[0147] 80 0.6 4.3 165 0.30
[0148]
[0149] With an increase in volumetric load, an increase in stroke volume was observed. Further, the beating frequency increased slightly with increasing volumetric load.
[0150] The above proof-of-concept studies may indicate that the measurement system 7000 and / or the cardiac model 50 may facilitate the volumetric performance characterization of (3D) cardiac chamber models 600 under scalable settings, thereby allowing the use of the measurement system 7000 and / or of the cardiac model 50 in one or more of commercial drug testing and disease modelling applications.
[0151] Fabrication of holder cups 320 comprising one or more electrodes 3221 Holder cups 320 comprising one or more electrodes 3221 each, were prepared for a plurality of modules 200 arranged in a first array 210. First, a monolithic element comprising the cup walls 321 of the plurality of modules 200 was provided. Further, Kapton® tape was provided as the electrically insulating material. For each module 200, two electrodes 3221 and two electrical tracks 3222 were provided. To design the electrodes 3221 and electrical tracks 3222, EasyEDA software was used. The design for the cup bases 322 in a first array 210 of size 3x4 (or 4x3) is depicted in Fig. 7A, where the thinner lines indicate the electrical tracks 3222, the circles indicate (the position of) the cup bases 322, the thicker lines and rectangles in the cup bases 322 indicate the electrodes 3221, and the smaller squares indicate connection points 3223 on the electrical tacks 3222, through which the electrodes 3221 may be connected to a power source. A combination of two inks, silver (ACI Materials, FS0142) and carbon (ACI Materials, SC 1502), was printed using NOVA (a material dispensing system from Voltera), to obtain a low electrical resistance while maintaining biocompatibility of the holder cup 320. Traces of the silver ink were printed onto the Kapton® tape with a trace width of 0.5-0.8 mm using a 27-gauge nozzle (Nordson EFD, 7018395), and cured on a hot plate for 5 minutes at 150 °C, to provide the electrical tacks 3222. Afterwards, carbon electrodes 3221 were printed in connection with the silver electrical tracks 3222 using a 25-gauge nozzle (Nordson EFD, 7018333), and cured in an oven at 80 °C for 10 minutes. The Kapton® tape comprising the cup bases 322 was then used to seal the monolithic element comprising the cup walls 321 from the bottom, to provide the holder cups 320 arranged in the first array 210. That is, preparing the holder 300 comprising the cup wall 321 and the cup base 322 may comprise (i) providing anelectrically insulating material, (ii) depositing electrically conductive material onto the electrically insulating material, and (iii) curing the electrically conductive material to provide the holder cup 320 (especially the cup base 322) comprising one or more electrodes 3221.
[0152] Fig. 7B schematically depicts a first array 210 comprising a plurality of modules 200, wherein the cup base 322 of each of the holder cups 320 comprises two electrodes 3221. For clarity, electrical tracks 3222 covered by the array of holder cups 320 are not depicted. Further, for clarity, the inserts 400 and holder lids 330 of all but two of the modules 200 are not depicted, to better show the configuration of the electrodes 3221 in the cup bases 322. As can be seen, the holder cup 320 may thus comprise one or more electrodes 3221.
[0153] Fig. 7C schematically depicts an exploded view of a first array 210 of holder cups 320. The first array 210 of holder cups 230 may comprise multiple components, such as at least a monolithic array of cup walls 321 and a monolithic array of cup bases 322. Further, in the embodiment of Fig. 7C, the first array 210 of holder cups 230 may comprise a support 323. The support 323 may comprise a plurality of support openings 3231, configured to support connectors which connect the connection points 3223 to an electrical device or power source. Especially, the support openings 3231 may support the connectors from a bottom of the array of cup bases 322, while the slits in the side of the array of cup walls 321 may support the connectors from a top of the array of cup bases 322. The support openings 3231 may further facilitate aligning the connectors with the connection points 3223.
[0154] The term “plurality” refers to two or more. The terms “substantially” or “essentially” herein, and similar terms, will be understood by the person skilled in the art. The terms “substantially” or “essentially” may include embodiments with “entirely”, “completely”, “all”, etc. Hence, in embodiments the adjective substantially or essentially may also be removed. Where applicable, the term “substantially” or the term “essentially” may relate to > 90%, such as > 95%, especially > 99%, even more especially > 99.5%, including 100%.
[0155] The term “comprise” may also have the meaning “consists of’. Hence, the term "comprising" may refer to "consisting of' and / or "containing at least the defined species and optionally one or more other species". Use of the verb "to comprise" and its conjugations does not exclude the presence of elements or steps other than those stated in a claim. Unless the context clearly requires otherwise, throughout the description and the claims, the words “comprise”, “comprising”, and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the sense of “including, but not limited to”.
[0156] The term “and / or” especially relates to one or more of the items mentioned before and after “and / or”. For instance, a phrase “item 1 and / or item 2”, and similar phrases,may relate to one or more of item 1 and item 2. Furthermore, the terms “first”, “second”, “third”, and the like, in the description and in the claims, may be used for distinguishing between similar elements and not necessarily for describing a sequential or chronological order. It is to be understood that the terms so used are interchangeable under appropriate circumstances and that the elements and / or (method) steps of the invention described herein are capable of operation in other sequences than described or illustrated herein.
[0157] The devices, apparatus, or systems may herein amongst others be described during operation. As will be clear to the person skilled in the art, the invention is not limited to methods of operation, or devices, apparatus, or systems in operation.
[0158] It should be noted that the above-mentioned embodiments illustrate rather than limit the invention, and that those skilled in the art will be able to design many alternative embodiments without departing from the scope of the appended claims. In the claims, any reference signs placed between parentheses shall not be construed as limiting the claim.
[0159] The article "a" or "an" preceding an element does not exclude the presence of a plurality of such elements.
[0160] The invention may be implemented by means of hardware comprising several distinct elements, and by means of a suitably programmed computer. In a device claim, or an apparatus claim, or a system claim, enumerating several means, several of these means may be embodied by one and the same item of hardware. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measures cannot be used to advantage. In yet a further aspect, the invention may (thus) provide a software product, which, when running on a computer, may be capable of bringing about (one or more embodiments of) the method as described herein.
[0161] The various aspects discussed in this patent can be combined in order to provide additional advantages. Further, the person skilled in the art will understand that embodiments can be combined, and that also more than two embodiments can be combined. Furthermore, some of the features can form the basis for one or more divisional applications.
Claims
CLAIMS:
1. A measurement system (7000) for measuring a cardiac functional parameter of a cardiac chamber model (600), wherein the measurement system (7000) comprises a distance sensor (710), a module (200), and a control system (720), wherein the module (200) comprises a holder (300) and an insert (400), wherein the holder (300) is configured to host the cardiac chamber model (600) and at least part of the insert (400), wherein the holder (300) comprises an alignment means (310); wherein the insert (400) comprises an alignment section (410) and a tubular element (420), wherein:the alignment section (410) comprises an alignment element (415), wherein the alignment element (415) is configured to interact with the alignment means (310), wherein the tubular element (420) is configured (i) intersecting with the alignment section (410), and (ii) extending from the alignment section (410) at an alignment section first face (411);the tubular element (420) has a first internal diameter (Di) at a tubular element first end (421), wherein 1.0 mm < Di < 2.0 mm; wherein the tubular element first end (421) is configured to extend into the holder (300); wherein the tubular element first end (421) comprises one or more first end protrusions (425); wherein the one or more first end protrusions (425) are configured to support the cardiac chamber model (600);the tubular element (420) has a second internal diameter (D2) at a tubular element second end (422) opposite the tubular element first end (421); wherein the tubular element (420) has a central axis (AT) perpendicular to the second internal diameter (D2); and the distance sensor (710) is configured to emit a sensor signal along a first axis (Ai) configured at a first angle (ai) with the central axis (AT); wherein oil < 20°; wherein the distance sensor (710) is configured to determine a distance to a fluid in the tubular element (420); wherein the distance sensor (710) is configured to provide a distance signal to the control system (720); and wherein the control system (720) is configured to determine the cardiac functional parameter based on the distance signal.
2. The measurement system (7000) according to claim 1, wherein the distance sensor (710) comprises an optical sensor, and wherein the sensor signal comprises an optical signal.
3. The measurement system (7000) according to any one of the preceding claims, wherein the measurement system (7000) further comprises a second sensor (740), wherein the second sensor (740) is configured to determine one or more of: (i) a first area (Aci) of the cardiac chamber model (600) in a first cross-section of the cardiac chamber model (600) parallel to the cental axis (AT), and (ii) a second area (Aci) of the cardiac chamber model (600) in a second cross-section of the cardiac chamber model (600) perpendicular to the central axis (AT); wherein the second sensor (740) is configured to provide a related second sensor signal to the control system (720), and wherein the control system (720) is configured to determine the cardiac functional parameter based on the distance signal and the second sensor signal.
4. The measurement system (7000) according to any one of the preceding claims, wherein the one or more first end protrusions (425) comprise a protruding disc (426), wherein the protruding disc (426) is configured protruding from the tubular element first end (421) by a protrusion width (Wp), and wherein the protrusion width (Wp) is selected from the range of 0.05-0.5 mm.
5. The measurement system (7000) according to any one of the preceding claims, wherein the alignment section (410) comprises an alignment section second face (412) opposite the alignment section first face (411); wherein the tubular element second end (422) is configured at a side of the alignment section second face (412); wherein the tubular element (420) comprises a tubular element top section (428); wherein the tubular element top section (428) has a second length (L2), wherein L2 > 4 mm; wherein 2.5 mm < D2 < 3.5 mm; and wherein the second internal diameter (D2) deviates < 10% over the second length (L2).
6. The measurement system (7000) according to any one of the preceding claims, wherein the tubular element (420) comprises a tubular element middle section (427), wherein the tubular element middle section (427) is configured intersecting the alignment section (410), wherein the tubular element middle section (427) has a third internal diameter (D3) at the alignment section first face (411), and a fourth internal diameter (D4) at a middle section second end (4272) opposite the alignment section first face (411), wherein 0.95*Di < D3 < 1.05*Di and 0.95*D2 < D4 < 1.05*D2, and wherein an internal diameter of the tubular element middle section (427) tapers from D4 to D3 along the tubular element middle section (427).
7. The measurement system (7000) according to any one of the preceding claims, wherein the holder (300) comprises a holder cup (320) and a holder lid (330), wherein the holder cup (320) is configured to host the cardiac chamber model (600), wherein the holder lid (330) comprises the alignment means (310) and a holder central opening (340), and wherein the insert (400) is configured at least partially extending through the holder central opening (340).
8. The measurement system (7000) according to claim 7, wherein the holder cup (320) comprises one or more electrodes (3221).
9. The measurement system (7000) according to any one of claims 7-8, wherein the holder lid (330) comprises a lid opening (331), wherein the alignment means (310) comprises an alignment protrusion (311), and wherein the alignment protrusion (311) is configured between the lid opening (331) and the holder central opening (340).
10. The measurement system (7000) according to any one of the preceding claims, wherein the measurement system (7000) comprises a plurality of modules (200) arranged in a first array (210), wherein the measurement system (7000) further comprises a movement element (730), wherein the movement element (730) is configured to control a position of the distance sensor (710) relative to the plurality of modules (200), and wherein the control system (720) is configured to control the movement element (730).
11. The measurement system (7000) according to any one of the preceding claims, wherein the cardiac functional parameter comprises one or more of an ejection fraction, a stroke volume, a stroke work, a pressure inside the cardiac chamber model (600), a beating frequency, a relaxation parameter, and a cardiac output.
12. A measurement method for measuring a cardiac functional parameter of a cardiac chamber model (600), wherein the measurement method comprises:providing a cardiac model (50), wherein the cardiac model (50) comprises the cardiac chamber model (600) supported by a tubular element (420), wherein the tubular element (420) has a first internal diameter (Di) at a tubular element first end (421), wherein 1.0 mm < Di < 2.0 mm; wherein the tubular element (420) has a second internal diameter (D2) at a tubular element second end (422) opposite the tubular element first end (421); wherein thetubular element first end (421) comprises one or more first end protrusions (425); wherein the one or more first end protrusions (425) are configured to support the cardiac chamber model (600);providing a sensor signal to the cardiac model (50) along a first axis (Ai); determining a distance to a fluid in the tubular element (420), and providing a distance signal to a control system (720); anddetermining the cardiac functional parameter based on the distance signal.
13. The measurement method according to claim 12, wherein the measurement method further comprises:determining one or more of (i) a first area (Am) of the cardiac chamber model (600) in a first cross-section parallel to the first axis (Ai), and (ii) a second area (Aci) of the cardiac chamber model (600) in a second cross-section perpendicular to the first axis (Ai); and determining the cardiac functional parameter based on the distance signal and the respective area.
14. The measurement method according to any one of claims 12-13, wherein the measurement method comprises one or more of (a) providing a drug or therapeutic to the cardiac chamber model (600), (b) providing a stimulus to the cardiac chamber model (600), and (c) mimicking a disease with the cardiac chamber model (600); wherein the measurement method further comprises determining a first cardiac functional parameter at a first time (ti), and determining a second cardiac functional parameter at a second time (tz).
15. A cardiac model (50) comprising a module (200), wherein the module (200) comprises a holder (300) and an insert (400), wherein the module (200) further comprises a fluid (540) and a cardiac chamber model (600); wherein the holder (300) is configured to host the fluid (540), the cardiac chamber model (600), and at least part of the insert (400); wherein the holder (300) comprises an alignment means (310); wherein the insert (400) comprises an alignment section (410) and a tubular element (420); wherein:the alignment section (410) comprises an alignment element (415), wherein the alignment element (415) is configured to interact with the alignment means (310), wherein the tubular element (420) is configured (i) intersecting with the alignment section (410), and (ii) extending from the alignment section (410) at an alignment section first face (411);the tubular element (420) has a first internal diameter (Di) at a tubular element first end (421), wherein 1.0 mm < Di < 2.0 mm; wherein the tubular element first end (421) is configured to extend into the holder (300); wherein the cardiac chamber model (600) is configured at the tubular element first end (421), wherein the tubular element first end (421) comprises one or more first end protrusions (425) configured to at least partially support the cardiac chamber model (600); wherein the cardiac chamber model (600) is configured at least partially submerged in the fluid (540);the tubular element (420) has a second internal diameter (D2) at a tubular element second end (422) opposite the tubular element first end (421); wherein the tubular element (420) has a central axis (AT) perpendicular to the second internal diameter (D2); and the cardiac chamber model (600) comprises first cells (52), wherein the first cells (52) comprise cardiomyocyte-like cells (521); wherein the cardiac chamber model (600) comprises a chamber cavity (610) and a chamber opening (620); wherein the chamber cavity (610) is configured to host the fluid (540); and wherein the chamber cavity (610) is configured fluidically coupled with the tubular element (420) via the chamber opening (620).
16. The cardiac model (50) according to claim 15, wherein the fluid (540) comprises a first fluid (541) and a second fluid (542), wherein the holder (300) is configured to host the first fluid (541), wherein the chamber cavity (610) is configured to host the second fluid (542), and wherein the first fluid (541) and second fluid (542) differ in one or more of a viscosity, a color, a composition, and a concentration of at least one component.
17. A method for preparing the cardiac model (50) according to any one of claims 15-16, wherein the method comprises:providing the holder (300) and a first molding element (30); wherein the holder (300) is configured to host the first molding element (30); wherein the first molding element (30) comprises a first molding material (31); wherein the first molding element (30) comprises a first cavity (35) defined by a first cavity wall (36);providing a cell culture (520) to the first cavity (35), wherein the cell culture (520) comprises first cells (52) and a first matrix solution (523); wherein the first cells (52) comprise cardiomyocyte-like cells (521);providing the insert (400) and a second molding element (40), wherein the second molding element (40) is configured at the tubular element first end (421); wherein the second molding element (40) comprises a second molding material (41);aligning the alignment element (415) with the alignment means (310), and at least partially inserting the second molding element (40) into the first cavity (35); wherein for at least 70% of the circumference of the second molding element (40) applies that the second molding element (40) is separated from the first cavity wall (36) by a first distance (di) selected from the range of 0.3-0.7 mm;crosslinking the first matrix solution (523) to provide a crosslinked cell culture (530); andexposing the crosslinked cell culture (530), the first molding material (31), and the second molding material (41) to a first temperature (Ti) to provide the cardiac model (50), wherein Ti > 33 °C.
18. The method according to claim 17, wherein one or more applies of: (a) the first cells (52) further comprise secondary cells (522), wherein the first cells (52) comprise the cardiomyocyte-like cells (521) and the secondary cells (522) in a ratio selected from the range of 4:1 to 34:1, (b) the cell culture (520) comprises the first cells (52) in a cell concentration (Cc) selected from the range of 20*106cells / ml to 40* 106cells / ml, (c) the first matrix solution (523) comprises one or more of fibrinogen, thrombin, a polymer, and collagen, and (d) the first matrix solution (523) further comprises a serine protease inhibitor in an inhibitor concentration (Ci) selected from the range of 1.5-3.5 pg / ml.
19. The method according to any one of the preceding claims 17-18, wherein the method further comprises preparing the first molding element (30), wherein preparing the first molding element (30) comprises:providing a first fluid molding material (3) and a first molding template (510); andadding the first fluid molding material (3) to the holder (300), inserting the first molding template (510) into the first fluid molding material (3), solidifying the first fluid molding material (3) to provide the first molding material (31), and removing the first molding template (510) to provide the first molding element (30) arranged in the holder (300); wherein solidifying the first fluid molding material (3) comprises cooling the first fluid molding material (3) to a second temperature (T2), wherein T2 < 15 °C.
20. The method according to any one of the preceding claims 17-19, wherein the method further comprises preparing the second molding element (40), wherein preparing the second molding element (40) comprises:providing a second molding template (550), the insert (400), and a second fluid molding material (4); wherein the second molding template (550) comprises a second molding cavity (551) and an insert cavity (552), wherein the second molding cavity (551) has an ovoid shape, and wherein the second molding cavity (551) and the insert cavity (552) are fluidically coupled;inserting at least part of the insert (400) into the insert cavity (552), wherein the tubular element first end (421) is configured at a first end of the second molding cavity (551);adding the second fluid molding material (4) to the second molding cavity (551), and solidifying the second fluid molding material (4) to provide the second molding material (41); andremoving the second molding template (550) to provide the second molding element (40) physically coupled with the tubular element first end (421).
21. The method according to any one of the preceding claims 17-20, wherein the method further comprises preparing the holder (300), wherein the holder (300) comprises a holder cup (320), wherein the holder cup (320) comprises one or more electrodes (3221), and wherein preparing the holder (300) comprises (i) providing an electrically insulating material, and (ii) depositing electrically conductive material onto the electrically insulating material.
22. A system (1000) for preparing a cardiac model (50), wherein the system (1000) comprises a module (200), wherein the module (200) comprises a holder (300) configured to host a first molding element (30), an insert (400), and a second molding element (40); wherein the holder (300) comprises an alignment means (310); wherein the first molding element (30) comprises a first molding material (31); wherein the first molding element (30) comprises a first cavity (35) defined by a first cavity wall (36); wherein the insert (400) comprises an alignment section (410) and a tubular element (420), wherein:the alignment section (410) comprises an alignment element (415), wherein the alignment element (415) is configured to interact with the alignment means (310), wherein the tubular element (420) is configured (i) intersecting with the alignment section (410), and (ii) extending from the alignment section (410) at an alignment section first face (411);the tubular element (420) has a first internal diameter (Di) at a tubular element first end (421), wherein 1.0 mm < Di < 2.0 mm; wherein the tubular element first end (421) comprises one or more first end protrusions (425); wherein the tubular element (420) has a second internal diameter (D2) at a tubular element second end (422) opposite the tubular element first end (421); andthe second molding element (40) is configured at the tubular element first end (421); wherein the second molding element (40) comprises a second molding material (41); wherein the second molding element (40) is configured to at least partially extend into the first cavity (35), and wherein for at least 70% of the circumference of the second molding element (40) applies that the second molding element (40) is separated from the first cavity wall (36) by a first distance (di) selected from the range of 0.3-0.7 mm.
23. The system (1000) according to claim 22, wherein the second molding element (40) has an ovoid shape, and wherein the second molding element (40) is configured fully arranged in the first cavity (35).
24. The system (1000) according to any one of claims 22-23, wherein the system (1000) comprises a plurality of modules (200) arranged in a first array (210), and wherein the plurality of modules (200) are configured mechanically coupled in the first array (210).
25. Use of the measurement system (7000) as defined in any one of claims 1-11 or of the cardiac model (50) as defined in any one of claims 15-16 for one or more of disease modelling, drug testing, drag screening, and targeted therapeutics.
